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Abbreviations: 
CASP, community wide experiment on the Critical Assessment of Techniques for Protein 
Structure Prediction; VLP, virus-like particle; TfR1, Transferrin Receptor 1; WWAV, 
Whitewater Arroyo Virus; GP1, glycoprotein 1; RG-II, Rhamnogalacturonan-II; HGM, Human 
gut microbiota; GH, Glycoside hydrolases (GH); IBP, ice binding protein; TH, thermal 
hysteresis; IRI, ice recrystallization inhibition. 
 
Author contributions: 
Names of the authors contributing to specific sections are provided in the sections’ titles; 
concept, abstract, introduction, editing and coordination - by AK, KF, JM and TS. 
 
Abstract 
The functional and biological significance of the selected CASP12 targets are described by 
the authors of the structures. The crystallographers discuss the most interesting structural 
features of the target proteins and assess whether these features were correctly reproduced in 
the predictions submitted to the CASP12 experiment.  
 
Introduction 
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Integrity of the CASP experiment rests on the blind prediction principle requesting 
models to be built on proteins of unknown structures. To get a supply of modeling targets, the 
CASP organization relies on the help of the experimental structural biology community. In 
the latest seven experiments (2002-2014), the vast majority (>80%) of CASP targets came 
from structural genomics centers participating in the Protein Structure Initiative (PSI) 
program. With the disintegration of the PSI in 2015, CASP faced a challenging task of 
replenishing the target supply normally provided by the PSI Centers. Dealing with this 
problem required diversification of target sources and going beyond the existing network of 
the recurring CASP target providers. Soliciting for targets, the organizers directly approached 
a wider set of structure determination groups, and also worked out a better protocol for 
obtaining and analyzing information about the structures placed on hold with the PDB. These 
efforts bore fruits, and 82 targets were secured for the CASP12 experiment. This number is 
quite impressive (considered that targets were collected in a short 3-month span of time) and 
is only somewhat smaller than the number of targets in a typical PSI-era CASP experiment 
(cf. 100 targets in the most recent CASP11 experiment). It is also worth mentioning that 
CASP12 targets came from 33 different protein crystallography groups stationed in 17 
countries worldwide. Because of this variety, CASP12 targets exhibited wide diversity of 
sizes (from 75 to 670 residues), difficulties (from high accuracy modeling targets to new 
folds), quaternary structure composition (from single-domain targets to hetero-complexes), 
organisms (from rare extremophilic archaea from the depths of the Red Sea to Homo 
Sapiens), and protein types (from globular to viral and membrane). Such diversity is vital for 
comprehensive testing of prediction methods. CASP organizers, who are co-authors of this 
paper, want to thank every experimentalist who contributed to CASP12 and this way helped 
developing more effective protein structure prediction methods. The list of all 
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crystallographers who contributed targets for the CASP12 experiment is provided in Table 1 
of the Supplementary material.  
This manuscript is the fourth in a series of CASP target highlight papers
1-3
. The chapters of 
the paper reflect the views of the contributing authors on twelve CASP12 targets: 1) the 
flagellar cap protein from Pseudomonas aeruginosa – T0886; 2) bacteriophage AP205 coat 
protein – T0859; 3) toxin-immunity protein complex from the contact-dependent growth 
inhibition system of Cupriavidus taiwanensi – T0884/T0885; 4) sorbitol dehydrogenase from 
Bradyrhizobium japonicum – T0889; 5) C-terminal domain of human gasdermin-B – T0948; 
6) receptor-binding domain of the whitewater arroyo virus glycoprotein – T0877; 7) glycoside 
hydrolase family 141 founding member BT1002 – T0912; 8) an DNA-binding protein from 
Aedes aegypti – T0890; 9) snake adenovirus-1 LH3 hexon-interlacing protein – T0909; 10) an 
ice-binding protein from Antarctica – T0883; 11) a domain of UDP-glucose glycoprotein 
glucosyltransferase from Chaetomium thermophilum – T0892; and 12) a cohesin from 
Ruminococcus flavefaciens scaffoldin protein complexed with a dockerin – T0921/T0922. 
The results of the comprehensive numerical evaluation of CASP12 models are available at the 
Prediction Center website (http://www.predictioncenter.org). The detailed assessment of the 
models by the assessors is provided elsewhere in this issue. 
 
1. FliD, the flagellar cap protein from Pseudomonas aeruginosa PAO1 (CASP: T0886, 
Ts886, PDB: 5FHY) – provided by Sandra Postel and Eric J. Sundberg. 
Bacterial flagella are long helical cell appendages that are important for bacterial 
motility and pathogenicity 
4
. These extracellular hollow filaments are formed by thousands of 
copies of FliC (flagellin) molecules and connected via a hook to the flagellar rotary motor 
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anchored in the bacterial membrane 
5
. The motor drives the propeller like motion of the 
filament that confers swimming motility to the bacteria 
6
. An important structural and 
functional component of bacterial flagella is the flagellar capping protein, FliD, that is located 
at the distal end of the flagellar filament 
7
. Unfolded FliC molecules are translocated from the 
cell cytoplasm through the hollow filament pore to the tip of the growing flagellum where 
FliD regulates flagellar assembly by chaperoning and sorting FliC proteins. An absence of 
FliD leads to improperly constructed filaments and, consequently, impaired bacterial motility 
and infectivity 
8
. In the most commonly studied organism for flagella, Salmonella serovar 
Typhimurium, FliD is known to form a homopentameric complex on the tip of the flagellum, 
as shown in a low-resolution cryo-EM structure 
7,9,10
. Until recently, these data provided the 
only available structural insight to FliD. Our crystal structure of a large fragment of FliD, 
FliD78-405, from Pseudomonas aeruginosa PAO1 was the first high-resolution structure of any 
FliD from any bacterium, providing novel details concerning FliD function 
11
. 
 In our crystal structure 
11
, the Pseudomonas FliD78-405 monomer exhibits an L-shaped 
structure (Figure 1A), which can be divided into two globular domains and a helical region. 
Domain D3 is a loop insertion into domain D2 and both domains have structural similarity to 
other flagellar proteins. Residues 309 to 405 of FliD78-405 are highly flexible as revealed by 
hydrogen/deuterium exchange (HDX) and, therefore, we were unable to model those residues 
in our structure. Full-length Pseudomonas FliD1-474 encodes predicted N- (residues 1 to 77) 
and C-terminal (residue 406 to 474) coiled coil domains that prohibited crystallization in our 
hands.  
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Figure 1.  
 
In contrast to the Salmonella FliD that forms a pentamer, Pseudomonas FliD adopts a 
hexameric oligomeric state in the crystal structure (Figure 1B), as well as in solution and 
functions as a hexamer in vivo 
11
. The number of protofilaments that comprise the flagellar 
filament upon which FliD oligomers reside varies between bacteria 
12
, suggesting that FliD 
oligomer stoichiometries also vary between bacteria, which is supported by our results. More 
recently, the crystal structure of FliD from E. coli that includes all residues except the N- and 
C-terminal coiled coils showed that this FliD protein also forms a hexamer 
13
. 
 Pseudomonas FliD was included in CASP12 as a regular target and small-angle X-ray 
scattering (SAXS)-assisted target. SAXS data of the monomeric full-length protein, FliD1-474, 
for which no crystal structure yet exists, was collected and the data provided to the modelers 
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to aid the structure prediction process of the shorter construct that we had crystallized. All the 
SAXS-assisted target models exhibit low similarity to the FliD crystal structure as shown in 
an overlay of the best model T0886TS036_1 with our crystal structure in Figure 1C, but do fit 
well into the SAXS envelope (Figure 1C).  
The models obtained during the regular prediction round without using the SAXS 
envelopes to assist model-building vary greatly. The highest ranked model T0886TS247_1 
closely resembles the crystal structure of Pseudomonas FliD78-405 on the individual domain 
level (Figure 1D). However, the connection between domain D2 (CASP domain D1) and 
domain D3 (CASP domain D2) diverges resulting in a relative positioning of these two 
domains that is different than in the crystal structure (Figure 1E). The multi-domain-like 
SAXS molecular envelope of FliD1-474 may have made it difficult to predict the exact 
positioning of the individual domains (Figure 1C). Residues 309 to 405 of FliD78-405, which 
we could not model in the crystal structure due to poor or missing electron density, were in 
general modeled as helical bundles in T0886TS247_1. A superposition with the recently 
solved crystal structure of E. coli FliD43-416 (PDB 5H5V 
13
) shows the correct prediction of 
helical bundles in those regions, but also places those bundles in a different orientation 
relative to the D2 and D3 domains, as well as differences in the placement of individual 
helices (Figure 1F). These discrepancies between model and structure may be due to the high 
flexibility in the linker region and in the helical regions that we detected by HDX
11
. 
Compared to T0886TS247_1, all of the other models exhibit substantially less 
similarity to the FliD78-405 crystal structure (Figure 1G). Models of domain D3 (CASP domain 
D2) alone, however, exhibited greater likenesses to the crystal structure with secondary 
structural elements generally predicted properly (Figure 1H). This might be related to the 
lower flexibility (as shown by HDX) of domain D3 in comparison to the rest of the FliD 
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molecule. Overall, FliD seemed to be a difficult target to model, despite the SAXS data 
provided, and only domain D3 appeared to yield more accurate models by multiple modeling 
groups. 
 
2. Structure of bacteriophage AP205 coat protein (CASP: T0859; PDB: 5FS4, 
5JZR, 5LQP) - provided by Kaspars Tars, Roman I. Koning and Guido Pintacuda. 
Virus-like particles (VLPs) are empty, non-infectious shells of viruses, devoid of 
genomic nucleic acid, but morphologically similar to the corresponding viruses. VLPs have 
several applications, the best known of which is vaccine development. For example, VLPs of 
Hepatitis B virus have been used as successful vaccines for a few decades
14
. VLPs can be 
used not only as vaccines against the disease, caused by the virus of VLP origin, but also as a 
powerful platform to induce strong immune response against virtually any antigen
15
. In this 
case, multiple copies of antigen of interest should be attached to the surface of VLP. The 
immune system recognizes patterns of regularly repeating antigens on VLP surface as a 
potential threat to organism, inducing highly elevated titres of antibodies and stronger T-cell 
responses
16
. To avoid pre-existing immune responses, non-human pathogens are preferable as 
carriers of antigens. For this purpose, VLPs of ssRNA phages like MS2, Qβ and AP205 have 
been widely used 
17
. ssRNA phages are among the simplest known viruses, used for decades 
as simple models to study various problems in molecular biology. Capsid of ssRNA phages 
contains 178 copies of coat protein (CP) and a single copy of maturation protein, responsible 
for attachment of phage particles to bacterial receptor
18
. When produced in bacteria, 
recombinant CP of ssRNA phages spontaneously assembles in VLPs, containing 180 copies 
of CP. Due to strong interactions between two adjacent CP monomers, VLPs can be regarded 
as built from 90 CP dimers. 
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For creation of vaccine candidate, the antigen of choice can be attached to VLPs either 
by chemical coupling or genetic fusion of CP and antigen genes. Genetic fusion is 
technologically more efficient, since production of vaccine candidate requires only a single 
protein expression and purification without a need for a chemical coupling step. Since 
antigens must be presented on the surface of VLPs, the knowledge of the exact three-
dimensional structure of VLP provides essential information about suitable sites of insertion 
of antigens in coat protein sequences. Due to folding problems, large insertions are often 
tolerated only at either N- or C-termini of CP, but this is possible only if the terminal end of 
CP is well exposed on the VLP surface. However, in VLPs of ssRNA phages studied so far, 
like MS2 
19, Qβ 20, GA 21, PP7 22, PRR1 23 and Cb5 24 both terminal ends are poorly exposed 
on the surface. Instead, a so-called AB loop is well exposed, but only relatively short amino 
acid sequences can be inserted in it without compromising VLP stability. In contrast, AP205 
VLPs have been known before to tolerate significantly longer insertions at both C- and N- 
termini
25
, but the structural reason for this remained unknown. Since we failed to obtain high 
resolution crystals of recombinant AP205 VLPs, we constructed and crystallized an assembly-
deficient AP205 CP mutant, capable to form dimers, but not VLPs. The obtained crystal 
structure was further fitted into a medium resolution cryo-EM map of native recombinant 
AP205 VLPs. Additionally, a solid-state NMR structure of AP205 coat protein was obtained 
from labelled AP205 VLPs. The obtained results revealed that compared to related ssRNA 
phages, structure AP205 CP is circularly permutated 
26
, meaning that about 20 N-terminal 
residues including the first beta strand are found at the C-terminal part instead. This feature is 
made possible due to the close proximity of N- and C-terminal parts of two monomers within 
the dimer (Figure2ab). The result is that in AP205 VLPs both N- and C- termini are found in 
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the same position as AB loops in other phages (Figure 2cd). This provides a structural basis 
for construction of vaccine candidates using AP205 VLPs. 
Figure 2. 
 
Out of 499 submitted CASP models, only one had a reasonably accurate overall structure 
(Figure 2e, red and blue). Model T0859TS001, made by researchers at Francis Crick institute 
included almost all of the actual secondary structure elements apart from the C-terminal beta 
strand, which is unique for AP205, compared to other similar phages. About one third of the 
protein, comprising approximately 40 N-terminal residues was placed fairly accurately in 
respect to sequence, as compared to the crystal structure. This means that researchers have 
correctly deduced that the first beta strand is missing in AP205. After residue 40, 
progressively increasing out-of-register errors occur in the model. At the C-terminal part the 
out-of-register shift is about 20 residues. Due to this shift, the C-terminal residues are 
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modelled as alpha-helix although in crystal structure they form the extra (C-terminal) beta 
strand, not observed in similar phages. Therefore, C-terminal part, is not modelled correctly 
and does not suggest the placement of C-termini on the surface of VLP, close to AB loops in 
related phages. Even though the overall precision of the model is somewhat limited, the 
model correctly suggests that N-terminal part is indeed well-exposed on the surface of VLP 
and occupies the position of AB loops in related phages. Therefore, in the absence of 
experimental data, the model T0859TS001 would provide significant biologically relevant 
information for construction of VLP based vaccines. 
 
3. Structure of the toxin-immunity protein complex from the contact-dependent 
growth inhibition system of Cupriavidus taiwanensis (CASP: T0884/T0885, PDB: 
5T87) – provided by Karolina Michalska, Christopher S. Hayes, Celia W. Goulding 
and Andrzej Joachimiak. 
Contact-dependent growth inhibition (CDI) is an important mechanism of inter-
cellular competition found in Gram-negative bacteria. CDI
+
 cells use CdiB-CdiA two-partner 
secretion systems to deliver protein toxins directly into neighboring bacteria 
27,28
. CdiB is an 
outer membrane transport protein exporting the CdiA effector onto the cell surface. CdiA 
recognizes specific receptors on susceptible bacteria and translocates its C-terminal toxin 
domain (CdiA-CT) into the target cell 
29-31
. CdiA proteins carry a variety of toxin domains, 
most commonly exhibiting nuclease or pore-forming activities 
32-35
. To protect against self-
inhibition, CDI
+
 bacteria produce CdiI immunity proteins, which bind and neutralize cognate 
CdiA-CT toxins. The variable CdiA-CT toxin region is usually demarcated by a conserved 
peptide motif, such as the VENN sequence found in enterobacterial CdiAs 
33
. Different CdiA-
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CTs can be fused to heterologous CdiA proteins at the VENN motif to generate novel 
chimeric effectors 
28,33,34
. 
 We have selected the CdiA-CT/CdiI
Ctai
 complex from Cupriavidus taiwanensis LMG 
19424 for structural analysis. PSI-BLAST searches for CdiA-CT
Ctai
 homologs recover several 
predicted S-type pyocins from Pseudomonas species and MafB toxins from Neisseria 
species
36
. Other hits include CdiA-CT domains from Rhizobium leguminosarum and 
Achromobacter strains, and Rhs peptide-repeat proteins from Streptomyces species. All of 
these homologs are predicted to mediate inter-bacterial competition 
37,38
, though none have 
been validated experimentally. An HHpred-based search identified the C-terminal domain of 
16S rRNA-cleaving colicin E3 
39,40
 as a possible structural homolog having 9% sequence 
identity to CdiA-CT
Ctai
. The CdiI
Ctai
 immunity protein is less conserved than CdiA-CT
Ctai
, 
with homologs sharing ~30-40% sequence identity. An HHpred analysis recovered proteins 
with α-helical hairpin repeats, with the armadillo-like γ-COP coatomer  (13% sequence 
identity with CdiI
Ctai
) being the closest match. 
 The 2.40 Å resolution crystal structure of the CdiA-CT/CdiI
Ctai
 complex (Figure 3A) 
shows that the toxin putative catalytic domain (75 residues) consists of a central four-stranded 
antiparallel β-sheet, sandwiched by two N- and C-terminal α-helices and one 310 helix. The 
immunity protein (116 residues) is composed of three consecutive α-hairpins creating an 
armadillo-like structure. The N-terminal β-strand of CdiICtai protrudes from the helical body to 
complement the CdiA-CT
Ctai
 β-sheet, potentially influencing toxin conformation. This 
arrangement also suggests that the N-terminal segment of CdiI
Ctai
 is likely disordered in the 
free CdiI
Ctai
. A Dali server search for CdiA-CT
Ctai
 homologs identified only low-similarity 
matches:  inorganic triphosphatase (Z-score 3.7, rmsd 3.3 Å, PDB:3TYP) (Figure 3B) and  
WW domain of human transcription elongation regulator 1 (Z-score 3.5, rmsd 2.9 Å, 
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PDB:2DK7). More distant hits include E. coli ParE toxin (Z-score 3.0, rmsd 2.4 Å, 
PDB:3KXE) (Figure 3C), which belongs to  the barnase/EndoU/colicin E5-D/RelE (BECR) 
family (PMID:22731697). Although structurally related, these toxins display different 
activities: ParE family poison DNA gyrase 
41
, RelE is a ribosome-dependent mRNase 
42
, and 
colicins D/E5 cleave the anticodon loops of specific tRNAs 
43
. Therefore, the exact 
biochemical function of CdiA-CT
Ctai
 cannot be predicted easily and may include RNase or 
DNase activity. The CdiI
Ctai
 fold is well-represented in the PDB and is a popular scaffold for 
designer proteins. The closest match corresponds to human deoxyhypusine hydroxylase (Z-
score 12.3, rmsd 2.0 Å, PDB:4D4Z), followed by protein phosphatase 2 (Z-score 12.3, rmsd 
2.5 Å, PDB:2IE3) and other proteins with virtually no sequence similarity to CdiI
Ctai
. Though 
many of the homologs engage in protein-protein interactions, none are annotated as an 
immunity protein. 
 
 
Figure 3. 
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 Antitoxin proteins often bind over nuclease toxin active sites to prevent substrate 
access. Typically, nuclease toxins are highly electropositive and the cognate immunity 
proteins carry complementary acidic residues to promote electrostatic interactions. CdiA-
CT
Ctai
 contains several basic residues, including conserved His212, His214 and Arg216 
(Figure 3A), which may be key catalytic residues. CdiI
Ctai
 is more electrostatically neutral 
than previously characterized immunity proteins. It directly interacts with the toxin's putative 
active site using conserved His72, Arg75 and Asp108 residues that form a hydrogen bond, 
stacking interaction and salt-bridge, respectively. As outlined above, β1 of CdiICtai 
complements the toxin
 
fold.  
 For the CASP12 competition, CdiA-CT
Ctai
 and CdiI
Ctai
 were modeled as monomers. 
Out of 43 total predictions, the best model of CdiA-CT
Ctai 
(T0884TS183_1-D1) was generated 
by QUARK, which uses ab initio algorithms with no global template information. This model 
scored 66 GDT_TS points (% residues under distance cutoff ≤ 4Å), 10 points higher than the 
next model T0884TS236_1-D1 generated by MULTICOM-CONSTRUCT and 
T0884TS287_1-D1 from MULTICOM-CLUSTER. The original model was further improved 
to GDT_TS of 76 by PKUSZ_Wu_group (TR884TS118_1). 
T0884TS183_1-D1 closely resembles the crystal structure, though helix α1 is misoriented and 
the β3-β4 hairpin is distorted (Figure 3D). However, we note that toxin helix α1 is constrained 
by the immunity protein in the CdiA-CT/CdiI
Ctai
 complex. Therefore, it is possible that the 
free toxin domain adopts the conformation predicted by the computational model. Toxin 
residues that interact with the immunity protein are generally located in proper positions, 
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though a more accurate prediction of β4 would provide better agreement for conserved 
His212 and His214. 
 CdiI
Ctai 
(T0885) is a more straightforward structure prediction target, with fewer 
discrepancies between the 43 predicted models. The best model, T0885TS005_2-D1 (Figure 
3E), was generated by BAKER-ROSETTASERVER with 88 GDT_TS points (or 92 without 
10 N-terminal residues). This score is 4 and 7 points higher than the subsequent structures 
T0885TS405_1-D1 generated by IntFold4, and T0885TS183_1-D1 produced by QUARK. 11 
more models scored within 15 points of the best scoring models. As we found with CdiA-
CT
Ctai, the major misalignments were observed for peripheral elements (β1 and the C-
terminus of helix α6) involved in protein-protein interactions. The N-terminally truncated 
variant of the protein achieved 95 GDT_TS in the refinement (TR885TS247_1-D1).  
 This example shows that computational prediction can yield models with correct folds, 
and when combined with sequence conservation analysis, can inform rational mutagenesis 
and biochemical analyses. Important questions remain on how to identify the best 
computational model in the absence of the experimental data. In addition, though in silico 
approaches often provide insights into protein-protein interactions, such models for the CdiA-
CT-CdiIC
tai
 complex failed to properly predict protein-protein interface, leaving the putative 
active site fully exposed. Thus crystal structures are still required to confidently determine 
conformational states important for function and catalysis. 
 
4. Sorbitol dehydrogenase (BjSDH) from Bradyrhizobium japonicum (CASP: 
T0889; PDB: 5JO9) - provided by Leila Lo Leggio, Folmer Fredslund and Gert-
Wieland Kohring. 
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Rare sugars are monosaccharides and their derivatives which are rare in nature and 
they have attracted interest for potential medical and food applications 
44
. Consequently, 
enzymes able to produce and interconvert rare sugars have also attracted attention. We 
initiated structural studies of BjSDH as part of a collaborative EU project devoted to the 
development of an electro-enzymatic flow-cell device for the production of rare sugars 
45
. 
Several enzymes were investigated in the study, and BjSDH was selected for structure 
determination due to some favorable properties. First of all, while BjSDH preferentially 
catalyses the oxidation of D-glucitol (a synonym for D-sorbitol) to D-fructose, it also can 
catalyse the oxidation of L-glucitol to the rare sugar D-sorbose with enzymatic cofactor 
regeneration and high D-sorbose yield 
46
 (Figure 4a). Sorbitol dehydrogenases are additionally 
of particular interest in biosensor technology, since D-sorbitol is a marker for onset of diabetes 
as well as a food ingredient 
47
. Furthermore, it is a thermostable enzyme with Tm of 62 ◦C 
46
, 
which is a desirable property for potential industrial use and biosensor technology, as 
thermostability often correlates with general stability. BjSDH is a Zn-independent short chain 
dehydrogenase using NAD
+
/NADH as non-covalently bound cofactor. 
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Figure 4. 
 
Structure determination 
48
 was not straightforward since the resolution was limited. 
The resolution could be estimated to 2.9Å according to CC1/2 of about 50% in the outer 
resolution shell 
49
, but closer to 3.2Å with more conventional evaluation of resolution limit at 
I/σ(I) around 2. Furthermore, the Molecular Replacement model chosen (PDB code 4NBU 50) 
was only 29 % sequence identical to target (after structure-based alignment). All the closest 
structural relatives identified with DALI after structure determination (reported in Fredslund 
et al 
48
), have only around 30% sequence identity, and while most are dehydrogenases, none 
are denoted as sorbitol dehydrogenases. BjSDH was co-crystallized with NAD
+
 and D-
glucitol. D-glucitol could be modelled in the electron density map and phosphate is clearly 
bound, mimicking part of the cofactor, however a full co-factor molecule could not be 
modelled. This is probably due to presence of 1.4 M NaH2PO4/K2HPO4 in the crystallization 
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conditions, competing with the cofactor. Although there is only one molecule in the 
asymmetric unit, the enzyme forms a tetramer in the crystal structure due to crystallographic 
symmetry, and this is also assumed to be the predominant form in solution 
48
.  
To see if structural features were correctly predicted by the top models in CASP12, we 
selected the 5 top scoring hits (based on GDT_TS) for compariosn. These 5 top models were 
based solely, or in part on PDB entry 2JAH (or the related 2JAP), clavulanic acid 
dehydrogenase from Streptomyces clavuligerus 
51
, which was also the top DALI hit. 
The structure showed that the catalytic tetrad (Asn112, Ser140, Tyr153 and Lys157 in 
BjSDH) present in short chain dehydrogenases is highly conserved structurally in BjSDH 
compared to similar dehydrogenases. The 5 top hits (based on GDT_TS) from CASP12 all, 
unsurprisingly, predict correctly the positioning of the catalytic residues.  
In contrast the length, sequence and conformation of the loop lid covering the active 
site is poorly conserved (Figure 4b), even in enzymes with relatively similar specificity like R. 
sphaeroides sorbitol dehydrogenase RsSDH 
52
. This loop is different in the 5 top scoring hits 
from CASP12 and the crystal structure, and indeed also in the model used for molecular 
replacement. Since the resolution of the crystal structure is limited, and this loop in particular 
was difficult to trace, there might be errors in the crystallographic model too, but the 
conformation of the loop from several CASP12 models is definitely incompatible with crystal 
packing (Figure 4c) and cannot accurately represent the conformation it assumes in the 
crystal. On the other hand, packing could have affected the conformation and furthermore, the 
loop is involved in ligand binding, which would not be taken into account explicitly by the 
modelling programs and could also affect its conformation. 
One of the most important features of BjSDH was its thermostability
46
, as the 
knowledge of its structural determinants may help stabilizing related enzymes by protein 
Page 22 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 22 
 
engineering. In particular, we compared the structure to the sorbitol dehydrogenase RsSDH, 
for which the melting temperature by CD spectroscopy was also measured and found to be 
much lower than for BjSDH under similar conditions (Tm of 47 ◦C vs 62◦C). One of the 
striking features in BjSDH is a much higher Proline/Glycine ratio compared to RsSDH, a 
feature which is obvious from the sequence and does not require knowledge of the 3D 
structure. An additional feature which is likely to affect stability becomes obvious only 
through analysis of the quaternary structure. As previously mentioned BjSDH is a tetramer in 
the structure and in solution, as are many members of the short chain dehydrogenase family, 
and probably also RsSDH
52
. In BjSDH, two monomers of the tetramer make strong 
interactions so that a continuous β-sheet is formed between the two monomers, while this is 
not the case in RsSDH, indicating a less stable tetramer in the latter (Figure 4d). As the top 
CASP12 models for BjSDH were all based on the clavulanic acid dehydrogenase structure, 
which shares tetrameric formation, including the continuous β-sheet between two monomers, 
the resulting top models of BjSDH all received this motif from the template and thus are 
modelled consistent with an intersubunit β-sheet formation, despite the fact that the models 
are monomeric. This is not surprising, since the determining factor in producing an accurate 
model of the interaction are the backbone atoms, and are thus easily transferred to a homology 
model. 
In conclusion, the top CASP12 models reproduce correctly some but not all 
biologically and biotechnologically interesting features of SDH, for example they cannot 
predict the lid loop conformation, as this loop is poorly conserved.  
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5. Crystal Structure of the C-terminal Domain of Human Gasdermin-B (CASP: 
T0948; PDB: 5TJ4, 5TJ2, 5TIB) - provided by Kinlin L. Chao and Osnat 
Herzberg. 
Biological Significance of Gasdermin-B. The human genome encodes four 
gasdermins (GSDMA-D) that are expressed in epithelial cells of the gastrointestinal tract and 
skin, regulating the maintenance of the epithelial cell barrier, normal cell proliferation, and 
differentiation processes via the lytic and non-lytic forms of programmed cell-death 
53,54
. 
Based on the different protein levels in cancers, human GSDMA, GSDMC and GSDMD are 
considered tumor suppressors and GSDMB (CASP12 target T0948), a tumor promoter. 
GSDMB amplification and GSDMB overexpression indicate poor response to HER2-targeted 
therapy in HER2-positive breast cancer 
55
. The N-terminal domain of gasdermins possesses 
membrane-binding activity, whereas the C-terminal domain autoregulates the lipid binding 
function. Multiple genome-wide association studies (GWAS) revealed a correlation between 
single nucleotide polymorphisms (SNPs) in the protein coding and transcriptional regulatory 
regions of the neighboring GSDMA, GSDMB and ORDML3 genes in the 17q12.2.1 loci with 
susceptibility to asthma 
56
, type 1 diabetes 
57,58, Crohn’s disease, ulcerative colitis 58,59 and 
rheumatoid arteritis 
58,60
. Pal and Moult identified 2 GSDMB SNPs (dbSNP:rs2305479 and 
dbSNP:rs2305480) in linkage disequilibrium with a marker of disease risk 
58
. They 
correspond to a Gly299 → Arg299 change (rs230549), and a Pro306 → Ser306 change 
(rs2305480) in the C-terminal domain of GSDMB (GSDMB_C) (numbering scheme 
according to Uniprot isoform Q8TAX9-1). Analyses of the 1000 Genomes Project 
Consortium data 
61
 showed co-occurrence of the 2 SNPs (Gly299:Pro306 or Arg299:Ser306) 
with ~50% occurrence of each combination in the general population (Pal and Moult, 
unpublished). Unlike monogenic diseases which are caused by high penetrance SNPs in single 
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genes, complex-trait diseases are associated with multiple low penetrance SNPs in multiple 
genes. Because of linkage disequilibrium, most of the SNPs present in a genome are actually 
not disease causative and the challenge for the large-scale genome sequencing is to reveal the 
disease causative SNPs.  The structural studies of GSDMB_C provided insights into the 
possible mechanisms that the SNPs may contribute to disease risk 
62
. 
Key features of Gasdermin-B C-terminal domain. The structure of mouse Gsdma3 
(PDB 5B5R, an orthologue of GSDMA) revealed a 2-domain protein connected by a long 
flexible linker. The N-terminal lipid-binding domain folds into an α+β structure and the C-
terminal inhibitory domain adopts an α-helical fold comprising 8 helices 63. The 7-helix 
bundle topology of GSDMB_C (α5-α11 in PDB 5TJ4, 5TJ2, 5TIB ) is the same as that of 
Gsdma3, except that it lacks a Gsdma3 subdomain comprising an α-helix and a 3-stranded β-
sheet between the last two α-helices (Fig 5A-C).  
 
Figure 5. 
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We determined three crystal structures of the GSDMB_C containing (1) the 
Arg299:Ser306 pair corresponding to individuals with increased disease risk, (2) the 
Gly299:Pro306 present in healthy individuals, and (3) the Gly299:Ser306 combination, one 
from each allele 
62
. The SNP residues at positions 299 and 306 are located on a loop 
connecting the α7 and α8 helices of GSDMB (Figure 1A&B). Three GSDMB_C structures 
provide 16 independently determined molecules in their asymmetric units: 6 with Ser at 
position 306 and 10 molecules with Pro at that position. All 16 versions of this loop contain a 
5-residue α-helix (α’, Pro309-Ser313) (Figure 5A&B). However, the loops with Ser306 adopt 
an additional well-ordered 4-residue helical turn (Met303-Ser306) between the α7 and α’ 
helices (Figure 5B). By contrast, the loops with a Pro306 do not form this helical turn and 
each assumes different backbone conformations 
62
. In addition, a Gly299→ Arg299 alters the 
charge distribution on the protein surface. Examination of the structures shows that, unlike a 
more flexible Ser306 side chain, Pro306 cannot be accommodated at the end of the helical 
turn because its side chain would clash with main chain carbonyl atoms of the preceding 
residues. One or both of these changes may contribute to the susceptibility of individuals to 
develop diseases by possibly modulating the selectivity and binding affinity of its N-terminal 
domain to lipids or the association with partner proteins, for example HSP90β or fatty acid 
synthase 
64
.  
CASP12 predictions for the functionally important regions of GSDMB_C (T0948). The 
166-residue GSDMB_C CASP12 target sequence (T0948) contained the Arg299:Ser306 pair 
found in individuals with increased disease risk (PDB 5TIB). The publication of the full-
length Gsdma3 structure shortly prior to the CASP12 prediction deadline provided a 
homologous template for T0948 (PDB 5B5R 
63
). T0948 and the 198 residues Gsdma3 C-
terminal domain share 34.5% sequence identity and super positioning yields a RMSD of 2.3 
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Å for 113 shared Cα positions (Figure 5C). However, a 33 amino acid Gsdma3 subdomain 
between α10 and the last helix (Gsdma3 α12 or GSDMB α11) corresponds to a disordered 
loop in GSDMB that is too short to form an analogous subdomain (Met366–Tyr382) 62, and 
therefore could not be predicted. This Gsdma3 region is functionally important because it 
interacts with a segment on the N-terminal domain that is involved in membrane disruption 
63
. 
A total of 422 predictions for T0948 were deposited in CASP12, and 150 of them had 
GDT_TS scores > 70. The Gsdma3-based models for T0948 were quite accurate for the well-
aligned core 7-helix bundle region, but not for the functionally important polymorphism loop. 
The superposed structures of GSDMB_C and the highest GDT_TS scored model from group 
251 (myprotein-me server, Skwark and colleagues) illustrate the similarity within the core 7-
helix bundle (Figure 5D). However, the predictions for the polymorphism loop conformation 
(i.e. residues Arg299–Val322 of GSDMB corresponding to Arg54-Val77 in T0948) were 
poor, presumably because the GSDMB loop is 8 residues longer than that of Gsdma3 and 
lacks significant sequence homology (Figure 5A 
62
). Encouragingly, many top models 
(although not TS251_1-D1, Figure 5D) predicted the α’ helix (Pro309-Ser313) in the 
polymorphism loop. However, its length was overestimated and its orientation was wrong in 
all cases. Large differences exist even for the position-specific alignment of the 
polymorphism loop closest to the crystal structure (e.g., group 330, Laufer_seed, Perez and 
colleagues - Figure 5E). No group reproduced in their prediction the 4-residue helical turn 
preceding Ser306, a key structural difference that distinguishes the GSDMB produced by IBD 
and asthma patients from that of healthy individuals. Thus, the GSDMB example shows that 
prediction of the conformations of large loops that deviate substantially from their template 
structures has not yet achieved the level of accuracy required for drawing conclusions about 
structure-function relationships. 
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6. Receptor-binding domain of the Whitewater Arroyo Virus glycoprotein: studying 
pathogenicity from a structural point of view (CASP: T0877; PDB: 5NSJ) – 
provided by Amir Shimon and Ron Diskin. 
A subgroup of the enveloped RNA viruses that are known as arenaviruses attach to 
Transferrin Receptor 1 (TfR1), a highly conserved housekeeping protein, and use it as their 
cellular receptor for cell entry. For binding to TfR1 and for subsequently catalyzing fusion 
between the viral and the host membranes, arenaviruses use a class-I trimeric spike complex 
of which the GP1 portion is serving for receptor binding. Several viruses from this group are 
pathogenic and can cause disease in humans, due to their ability to utilize the human-TfR1 
(hTfR1) in addition to TfR1 from rodents, which are the natural reservoir of these viruses. 
Since both pathogenic and non-pathogenic arenaviruses use similar rodent-TfR1 
receptors but only the pathogenic viruses can utilize hTfR1, we wanted to understand what the 
structural barriers are that prevent non-pathogenic viruses from doing so. This information is 
important if we want to understand the molecular mechanisms that may allow non-pathogenic 
viruses to emerge into the human population as novel pathogens. Our model system for 
studying such structural barriers is the non-pathogenic Whitewater Arroyo virus (WWAV) 
65,66
. Critical structural information that allows us to perform this study is the crystal structure 
of a GP1 from the pathogenic Machupo arenavirus in complex with hTfR1 that was solved by 
the Harrison group 
67
. Based on the crystal structure of WWAV-GP1 that we have solved and 
using the structural information of the Machupo-GP1/hTfR1, we were able to model a 
putative complex of WWAV-GP1 / hTfR1 (Figure 6A). Relevant to this effort is the 
observation that Machupo-GP1 fully adopts a TfR1-compatible conformation when it is in the 
unbound state
68
. 
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Figure 6.  
 
After modeling the WWAV-GP1 / hTfR1 complex we conducted structural analysis to 
identify potential barriers that may account for the incompatibility of these two proteins.  This 
analysis indicated that there are two prominent structural barriers on hTfR1 that interfere with 
the binding of WWAV-GP1 (Figure 6B), compared to binding of TfR1-orthologs from 
rodents. Interestingly, the same incompatibilities equally affect the binding of GP1 from 
pathogenic viruses. The reason that pathogenic viruses can engage with hTfR1 is a more 
elaborate set of weak interactions that they evolved to form with TfR1 that allows them to 
overcome the energetic cost associated with the structural incompatibilities. Although there 
are some conserved interactions that GP1 from different viruses form with TfR1, many of the 
interactions are virus-specific leading to an overall altered TfR1 binding sites. Thus, targeting 
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the receptor-binding site of these viruses using classical immunotherapy approach or 
designing GP1-based vaccines may fail to provide broad response that would be effective 
against different members of this family of viruses.  
To be able to construct and analyze a putative complex of WWAV-GP1/hTfR1, we 
had to have an accurate structure of WWAV-GP1. Sequence conservation of viral 
glycoproteins like the GP1 domains from TfR1-tropic viruses is generally very low, due to 
rapid evolution under strong immunological pressure. Thus, a modeling approach may not 
fully reveal the fine details that are needed for such an analysis. In CASP12, the GP1 domain 
from WWAV was designated as a target for automated servers. Most of the predictors were 
able to provide models that faithfully represent the overall structure of this domain with 
GDT_TS > 50. We compared the top three models to the crystal structure of WWAV-GP1 
(Figure 6C). ‘MULTICOM-CONSTRUCT’, ‘MULTICOM-NOVEL’, and ‘GOAL’ achieved 
the best overall ranking with GDT_TS of 67.78, 68.66, and 70.25, respectively. The central β-
sheet and the α-helices were modeled correctly along the primary structure but slightly 
deviate from their real positions (Figure 6C). Interestingly, a disulfide bond that WWAV has 
but is not shared by GP1 domains for which structural information was previously available, 
was not modeled although the cysteine residues were placed in their correct orientations 
(Figure 6C). Since this bond influences the local geometry of a near-by loop, the modelers 
were unable to accurately model its conformation (Figure 6C). In general, the conformations 
of the loops from the various predictors cluster together, but in conformations that deviate 
from the real structure of WWAV-GP1. Considering the goal of our study, this is a major 
drawback since some of the important contacts that GP1 makes with TfR1 are mediated 
through these loops (Figure 6B). Thus, modeling loops is a challenging task and since loops 
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are often involved in protein-protein interactions bona fide structural information would be 
preferred for the type of analysis that we have performed.   
 
7. Structure features and biological significance of a new glycoside hydrolase family 
141 founding member BT1002 (CASP: T0912; PDB: 5MPQ) - provided by Didier 
Ndeh, Arnaud Baslé and Harry J. Gilbert. 
Rhamnogalacturonan II (RG-II) is a primary cell wall pectin of plants present in fruits, 
vegetables, wine and chocolate. It is the most complex carbohydrate known and despite its 
remarkable structural complexity, it is highly conserved across the plant kingdom 
69,70
. RGII 
is a 10 kda acidic polysaccharide and the structure has recently been revised 
69,71
. It consists of 
12 different sugars held together in the main structure by at least 21 glycosidic linkages. The 
basic structure is a linear backbone of α-(1-4)-linked D-galacturonic acid decorated 
stochastically at O2 with two highly complex octa- and enneasaccharide side chains (chains A 
and B respectively) and at O3 with two disaccharides chains (chains C and D) and 
monosaccharide side chains (chains E and F). To elucidate how the human gut microbiota 
(HGM) has evolved to utilise complex glycans in the diet we investigated the RG-II 
degradome of the prominent gut microbe Bacteroides thetaiotaomicron. The organism is 
capable of metabolising RGII in in-vitro growth experiments, and combined transcriptomic 
and biochemical data revealed that at least 23 enzymes induced in culture conditions with 
RGII as the sole carbon source are directly involved in its metabolism 
71,72
. The organism is 
capable of cleaving 20 out of the 21 unique glycosidic linkages in RG-II and biochemical 
evidence suggests that the CASP12 target T0912 (BT1002) is one of 7 novel enzymes 
recruited by B. thetaiotaomicron to achieve this purpose
71
.  
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BT1002 is a novel α-L-fucosidase and founding member of the new glycoside 
hydrolase family 141 (GH141) 
73
. BT1002 targets the complex tetrasaccharide structure; 2-O-
methyl-α-D-xylose-1,3-α-L-fucose-1,4-α-L-rhamnose-1,3’-β-apiose (mXFRA) that spans the 
length of RGII side chain-A. The products of mXFRA hydrolysis are the two disaccharides 2-
O-methyl-α-D-xylose-1,3-α-L-fucose (-1 subsite) and α-L-rhamnose-1,3’-β-apiose (+1 
subsite). As the -1 subsite fucose in mXFRA is substituted at O3 with 2-O-methyl-α-D-
xylose, the enzyme must have an extended pocket to accommodate this substitution. The 
importance of BT1002 in RGII metabolism is exemplified by the fact that genetic mutants 
lacking the enzyme are unable to metabolise mXFRA during in-vitro growth on RGII, leading 
to accumulation mXFRA in the growth medium. This implies that the enzyme is unique and 
indispensable for the breakdown of its target in RGII.  
 
Figure 7. 
We solved BT1002 phase problem using selenomethionine single-wavelength 
anomalous diffraction. The crystallized construct diffracted up to a resolution of 2Å. It 
comprises 624 amino acids of which 605 are visible in the PDB model (5MQP). BT1002 
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contains 12 alpha helices and 50 beta-strands forming 6 sheets. The catalytic domain is made 
of the C-terminal and N-terminal ends of the protein (residues 19-113 and 300-618 
respectively) that fold into a beta-parallel helix. An extended loop of the catalytic domain 
comprising residues 323 to 370 mediates contacts between the beta-parallel helix and the 
beta-sandwich domains (D1 and D2) made of residues 114 to 299. Additionally the domain 
D3 is flanked by two alpha-helices (Figure 7, panel A). While efforts to identify specific 
active site interactions between BT1002 and its tetrasaccharide target are ongoing, we 
identified two aspartates (Asp523 and Asp564) as potential catalytic residues through site 
directed mutagenesis
71
. The residues are 6.1 Å apart in a pocket suggesting an acid-base 
assisted double displacement mechanism. The closest structural homolog we found using a 
DALI search with the catalytic domain was a GH-120 beta-xylosidase (PDB code 3VSU) 
with a root mean square deviation of 2.7 Å. While the active site pockets were conserved their 
primary sequence (20% identity), the catalytic centre and specificity are very different.  
BT1002 as a CASP12 target was evaluated in full as well as the catalytic domain D1 (residues 
24-113 and 299-622). Additionally domains D2 (114-154 and 258-299) and D3 (155-257) 
were evaluated as targets but their biological significance is not clear. Prediction for the full 
target was successful overall with 54 models having a GDT_TS score above 30. The model 
with the highest GDT_TS score is T0912TS303_1 from the wfMESHI-TIGRESS group. To 
illustrate how well different regions of the protein are predicted, we aligned the BT1002 
crystal structure with a mid-range model (T0912TS349_1, HHPred1, GDT_TS 40.78). The 
result is presented in figure 7 (panel A) where colder colors indicate a close match and hotter 
colors a higher RMSD (residues in grey were not used). The catalytic domain D1 backbone 
was very well predicted with the 11 parallel beta-strand stacks of the beta-helix correctly 
identified (66 predicted models have a GDT_TS above 30 in the T0912-D1 category). This is 
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not surprising as such a domain had been solved structurally 24 years ago and is well 
described with multiple examples in the PDB data bank. Side chain positioning is more 
distant to the crystal protein structure. For instance the catalytic residues Asp564 and Asp523 
are distant by about 9 Å in the best D1 model rather than 6.1 Å in the crystal structure. The 
domain D2 was less correctly modelled overall (58 predicted model with a GDT_TS above 
30). Finally the third domain was poorly predicted (only one model with a GDT_TS above 
30). The best D3 model T0912TS247_1-D3 from the BAKER group correctly predicted the 
beta-strands and the beta sandwich but with a registry error. As a consequence, the flanking 
alpha helices were missed. The overall fold prediction accuracy is essential for this target. 
Indeed the binding pocket important for ligand recognition and binding, is not only 
constituted of the surface of the catalytic domain D1 and its extended loop but also the surface 
of domain D3. Therefore we had to consider only the full target predictions. Figure 7 (panel 
B) shows an overlay of the best predicted model (T0912TS303_1) and the PDB model 
(5MQP). The PDB model surface represented as a yellow mesh is clearly smaller than the 
predicted model surface in dark grey. Additionally the putative catalytic residues are more 
distant in the predicted model (magenta surface) than in the PDB model (red mesh).    
In summary, the BT1002 structure prediction results are very encouraging but shows 
the challenges facing the community in order to elucidate complex biological functions.  
 
8. A cryptic DNA-binding protein from Aedes aegypti (CASP: T0890; PDB: N/A) - 
provided by Reinhard Albrecht and Marcus D. Hartmann. 
During their development, pupating insects (holometabola) may accumulate uracil in 
the DNA of larval tissues. The protein UDE has been implicated in the development of 
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holometabola in the late larval stages as a uracil-DNA degrading factor. At the time of its 
experimental identification in Drosophila larval extracts, homologs were only found in 
holometabola
74
. Its sequence revealed a domain organization with a tandem sequence repeat 
in the N-terminal half, and several conserved motifs in the C-terminal half of the protein. In 
some holometabola, only one copy of the N-terminal tandem repeat is found, and it was 
shown for UDE from Drosophila melanogaster (DmUDE), that the first copy of the tandem 
repeat may be functionally dispensable
75
. Now, however, with more genomes sequenced, 
sequence searches result in a more diverse picture, including UDE proteins with a more 
complex domain arrangement in holometabola, but also homologs in plant-pathogenic fungi. 
With its developmental implications and due to the absence of sequence matches to 
domains of known structure, UDE potentially posed an attractive target for the development 
of insecticides specific to holometabola, or fungicides specific to certain plant pathogens. 
Initially, UDE caught our attention as we just had identified a novel uracil-recognition mode 
in the protein cereblon, which we thought could be linked to the recognition of uracil in DNA, 
and which was in competition to the binding of the drug thalidomide 
76,77
. Inspired by the 
topicality of the Zika virus at that time, we decided to tackle the UDE protein from the yellow 
fever mosquito Aedes aegypti (AaUDE; AAEL003864), a major virus vector.  
AaUDE is a canonical UDE protein with the N-terminal tandem repeat and a length of 
306 residues; In vitro, it showed DNA binding properties similar to DmUDE. While full-
length AaUDE withstood crystallization attempts, a recombinant protein corresponding to a 
proteolytic fragment encompassing residues 87-277, thus omitting the first copy of the tandem 
repeat and the potentially flexible C-terminal end, yielded well-diffracting crystals. The 
structure, which we solved via SAD phasing using a platinum derivative, shows an all-helical 
two-domain protein. The N-terminal domain corresponds to the second copy of the tandem 
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repeat and forms a three-helix bundle, while the C-terminal half is folded into a compact 
domain consisting of six helices (Figure 8A). 
 
Figure 8.  
 
A DALI search with the full structure yields countless hits for the N-terminal domain 
with Z-scores of up to 7.5. It had previously been predicted to be a three-helix bundle and had 
been implicated in DNA binding
75
. This notion is supported by our crystal structure, as this 
domain presents longer stretches of positively charged residues along its helices. However, 
the highest-scoring DALI hit is a single - and the only - hit for the C-terminal domain. With a 
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Z-score of 10.1 it matches a non-conserved additional C-terminal domain of the mimivirus 
sulfhydryl oxidase R596, which had previously been described as an ORFan domain of novel 
fold, and which is functionally not understood
78
 (Figure 8B). 
For the CASP predictors, AaUDE posed a tough but not intractable target. There were 
many good predictions for the simpler N-terminal domain, and a few good predictions for the 
C-terminal domain. Curiously, none of the groups could predict both domains. The five best 
overall models, ranging between a GDT_TS of 44.7 and 33.4 (submitted by the Seok-server, 
HHGG, HHPred1, HHPred0 and tsspred2) owe their accuracy to the correctly identified 
similarity of the C-terminal domain to the aforementioned mimivirus ORFan domain. They 
do, however, not reasonably predict the N-terminal domain. The overall models from rank 6 
on mostly contain fair-to-good predictions of the N-terminal but not the C-terminal domain, 
as they missed the link to the mimivirus protein. The best-matching predictions for the 
individual domains are depicted in Figure 8C and 8D.  
 
9. The snake adenovirus 1 LH3 hexon-interlacing protein (CASP: T0909; PDB: 
5G5N and 5G5O) – provided by Thanh H. Nguyen and Mark J van Raaij. 
Adenoviruses are non-enveloped double-stranded DNA viruses that infect vertebrates. 
Five genera of adenoviruses are known: Mastadenoviruses (infecting mammals), 
Aviadenoviruses (infecting birds), Ichtadenoviruses (infecting fish), Siadenoviruses (infecting 
certain birds and amphibian species) and Atadenoviruses (infecting birds, snakes, lizards, 
ruminants and possums). From the vertices of the icosahedral adenovirus particles (diameter 
around 100 nm), fiber proteins protrude that are responsible for primary host cell 
recognition
79
. Internalization in human adenoviruses is mediated by the penton base protein, 
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but some other adenoviruses lack the necessary integrin-binding sequence. The LH3 gene is a 
genus-specific Atadenovirus gene found at the left end of the genome, near to the p32K gene. 
Both LH3 and p32K gene products are believed to be involved in stabilization of the viral 
capsid
80,81
. The LH3 protein forms trimeric protrusions on the faces of the Atadenovirus 
particle
81
, wedged in between three H3 hexons and between the H2, H3, and H4 hexons. In 
total, four LH3 trimers are present on each of the faces, and 80 in the entire Atadenovirus 
particle. 
The Snake Atadenovirus 1 LH3 protein was expressed in E. coli, crystallized, the 
structure was solved using SAD from a mercury derivative crystal, and the structure was 
refined using native data of a different crystal form at 2.0 Å resolution. Evidence of 
proteolysis was observed and is consistent with the first 25 residues missing from the 
experimentally determined structure. The structure revealed a compact, knob-like trimer of 
right-handed beta-helices, as predicted by the BetaWrap server 
82
. The missing part was 
evident when fitting structure into an overall knob-like shape resulted by SAXS data 
(Figure 9) and in an overall 11 Å averaged cryo-EM map of SnAdV-1. 
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Figure 9.  
Each LH3 monomer contains of eleven beta-helical rungs stacked on top of each other. 
Each beta-helical rung consists of three beta-strands that form long anti-parallel beta-sheets 
with their counterparts from the other rungs. The beta-sheets are named PB1, PB2 and PB3, 
following the nomenclature proposed by Mayans 
83
. Turns between beta-strands are named T1 
(between PB1 and PB2), T2 (between PB2 and PB3), and T3 (between PB3 and PB1). PB1 
connects to PB2 mainly by short beta-turns, at the trimer interface, while PB2 connects to 
PB3 and PB3 to PB1 by longer loops. 
Amino acid ladders are observed in the structure of the LH3 protein, as is common for 
beta-helical structures
83,84
. Asparagine-, isoleucine- and phenylalanine-ladders are found in 
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the core of each monomer, stabilizing the basic beta-helical architecture of the monomer. The 
asparagine ladder (residues 193, 214, 248 and 291) is located right at the T1 turn, while the 
isoleucine (residues 68, 98, 134, 167, 311, 357) and phenylalanine (residues 103, 139, 172, 
195) ladders are found in the PB1 and PB2 sheets, respectively. A mixed isoleucine/leucine 
ladder (Ile84, Leu125, Ile147 and Ile179) in the PB3 sheet. It is possible that the hydrogen 
bonds in the asparagine ladder helps to avoid out-of-register interactions when the beta-helix 
folds. 
A structural homology search using the DALI server
85
 showed the best matches for 
tailspikes from Bacillus phage phi29 
86
, Shigella phage Sf6 
87
 and Salmonella phage P22 
88
. 
Structure superposition between SnAdV-1 LH3 and Sf6 TSP with its ligands revealed a 
strikingly similar beta-helix topology, despite the low sequence identity (about 13%). It 
should be noted that the Shigella phage SF6 tailspike has endorhamnosidase activity. At the 
binding site, loops from T2 and T3 turns were identified to involve in the interaction with the 
lipopolysaccharide substrate. Superimposition between two structures did not show 
conservation at the loop conformations, however, it is possible to form a potential inter-
subunit binding groove in the structure of SnAdV-1 LH3 or on the surface of a single 
monomer like in the phage P22 tailspike 
88
. Evidence for non-conserved binding sites among 
bacteriophage tailspike proteins was discussed previously 
89
. The structural similarity with 
bacteriophage tailspikes and its location on the viral cell surface suggested the LH3 protein 
may be involved in binding a (carbohydrate) ligand. However, we have not been able to 
demonstrate this or a role for the LH3 protein in host interaction. 
Structural superimposition between the crystal structure and the best CASP12 model 
(T0909TS303_5) showed a very similar beta-helical fold between the two. The beta-helix 
motif was predicted correctly. The best model, with a GDT_TS score greater than 60, 
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suggested a model comprising three anti-parallel beta-sheets PB1, PB2 and PB3 connected by 
beta-turns T1, T2 and T3, as observed in the experimentally determined structure. The length 
and orientation of beta-strands are represented quite accurately, although there are some 
mismatches or beta-strands missing in the best predicted model. Surface loop conformations 
are, as expected, predicted less reliably. Structure superimposition of different predicted 
models also showed that the main beta-helix is present generally but loop conformations are 
very distinct. Careful inspection of the predicted models shows that most of the beta-strands 
are well represented in the predicted models in terms of length and location, given that there is 
low sequence identity of SnAdV-1 LH3 protein with known structures (less than 15%). 
It should be kept in mind that SnAdV-1 LH3 protein is a homotrimer. However, the 
predictions did not take this given feature into account. If they would have, it is likely an 
overall correct trimeric model could hav  been derived, which in turn, might have allowed us 
to solve the structure by molecular replacement without having to resort to a heavy atom 
derivative. Availability of a SAXS envelope might also have helped to derive an accurate 
trimeric model computationally.  
 
10. Crystal structure of an ice binding protein from an Antarctic Biological 
Consortium (CASP:T0883; PDB:N/A) – provided by Valentina Nardone, Marco 
Mangiagalli and Marco Nardini). 
Organisms exposed to permanent subzero temperatures or seasonal temperature 
dropping are protected from freezing damage by producing Ice Binding Proteins (IBPs) which 
adsorb to the ice surface and stop ice crystal growth in a non-colligative manner
90
. A 
measurable effect of ice binding is that IBPs decrease the water freezing temperature, thereby 
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creating a thermal hysteresis (TH) gap between the melting and the freezing temperature
91
. 
TH has been explained by the fact that IBP induces a micro curvature on the ice surface. In 
this way, ice growth is restricted in between the adsorbed IBP and the curved surface. This 
makes the association of other water molecules thermodynamically unfavorable, causing the 
decrease of water freezing temperature. The second activity of IBPs is the ice recrystallization 
inhibition (IRI), that consists in the growth of large ice crystals at the expenses of smaller 
ones. Ice recrystallization is involved in dehydration and cellular damage and it is very 
injurious for biological matter
92
. Because of these properties, in recent years the potential 
application of IBPs has been recognized in several different fields in which materials and 
substances have to be preserved from freezing, including food processing, cryopreservation, 
cryosurgery, fishery and agricultural industries, and anti-icing materials development
90,93
.  
IBPs have been isolated in different species, including fishes, insects, plants, algae, 
fungi, yeasts and bacteria. Proteins from different sources share the ability to bind ice crystals, 
but they can exhibit very diverse 3D structures, including small globular proteins, single α-
helices, four helix bundles, polyproline type II helix bundles and β-solenoids. Overall, these 
observations suggest that IBP distribution originates from independent and combined 
evolutionary events, such as convergent evolution and horizontal gene transfer 
90
. 
Structural studies may contribute to better delineate the “natural history” and the 
function of IBPs. For instance, many IBPs share threonine-rich repeats, such as Thr-X-Thr or 
Thr-X-Asx, forming large surfaces complementary to ice crystals. The comparisons of 
threonine repeats forming the ice-binding sites of structurally very diverse IBPs could help to 
recognize the core elements involved in ice binding and to understand its mechanism 
90
. 
Among different IBPs, we focused our attention on EfcIBP, a bacterial IBP identified 
by metagenomic analysis of the Antarctic ciliate Euplotes focardii and the associated bacterial 
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consortium. Tested for its effects on ice, recombinant EfcIBP shows atypical combination of 
TH and IRI activities not reported in other bacterial IBPs. Its TH activity was 0.53 °C at 50 
µM, but it presented high IRI activity with an effective concentration in the nanomolar range. 
This value is one of the best described to date. As a result, EfcIBP effectively protected 
purified proteins and bacterial cells from damages deriving freezing. Furthermore, the 
presence in the EfcIBP sequence of a secretion signal seems to indicate that EfcIBP might be 
either concentrated around cells or anchored at the outer cell surface, permitting the entire 
consortium to thrive/survive at challenging temperature 
94
. To shed light on the antifreeze 
properties of EfcIBP at the molecular level it is crucial to elucidate its ice-binding mechanism 
through a combination of structural and molecular biology studies. Therefore, we decided to 
solve the EfcIBP structure by means of X-ray crystallography. 
EfcIBP crystals diffracted to atomic resolution (up to 0.84 Å), and the EfcIBP structure was 
solved by molecular replacement with the crystal structure of the IBP from the antarctic 
bacteria Colwellia sp. (PDB-code 3WP9; DALI Z-score of 32.3, residue identity of 38%) as a 
search model 
95
. The overall structure of EfcIBP consists of a right-handed β-helix with a 
triangular cross-section formed by three faces made by parallel β-sheets, and by an additional 
single 5-turn α-helix, aligned along the axis of the β-helix. The first face of the β-helix (9 β-
strands) is screened from the solvent region by the long α-helix and by the N-terminal region. 
This protein surface is, therefore, not suited for the interaction with ice crystals. The second 
face (8 β-strands) is flat and regular, while the third (8 β-strands) is only partly flat, with two 
β-strands which markedly diverge towards the exterior of the protein body. The latter two 
faces are fully exposed to the solvent region and, therefore, potentially suited for the 
interaction with ice crystals. 
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Overall, the CASP12 results indicate that right-handed β-helix can be predicted 
extremely well. All β-strands of the three faces of the EfcIBP structure are correctly 
positioned as well as the 5-turn α-helix, aligned along the β-helix axis. It should be noted, 
however, that the β-strand located immediately after the α-helix is correctly placed within the 
β-helix fold, but is shifted of two residues in sequence, meaning that the loop before this β-
strand is two-residue longer and the loop after is two-residue shorter. The top ten ranked 
models (CASP GDT_TS score >89.0) are characterized by an RMSD of ~1.4 Å for the core 
of the protein (181 Cα pairs over 207 residues), devoid of the first 9 N-terminal residues. The 
structure of this terminal segment is not predicted correctly partly because this region is 
shorter in the homologous proteins used as templates, partly because its conformation might 
be selected by crystal contacts and, therefore, difficult to predict. 
CASP12 is also able to model correctly a deletion at the top of the right-handed β-
helix, where in homologous proteins is present a small cap subdomain (about 12 residues). In 
this region, however, the Gly-Pro-Pro sequence at the closure of the deletion does not 
superimpose well with the corresponding EfcIBP crystal structure. 
Interestingly, the overall quality of the CASP12 prediction does not seem to improve 
significantly when multiple protein templates are used for modeling instead of a single 
template. This is probably due to the high structural conservation and rigidity of the β-helix 
scaffold which is reproduced similarly in all protein templates. 
 
11. The TRXL1 domain of Chaetomium thermophilum UGGT (CASP: T0892; PDB: 
5MU1, 5MZO, 5N2J and 5NV4) – provided by Pietro Roversi, Alessandro T. 
Caputo, Johan C. Hill and Nicole Zitzmann. 
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One of the last unsolved mysteries of the eukaryotic endoplasmic reticulum 
glycoprotein folding quality control (ERQC) machinery is its single checkpoint enzyme, the 
ER UDP-glucose glycoprotein glucosyltransferase (UGGT). Once monoglucosylated by this 
enzyme, glycoproteins are retained in the ER bound to the lectins calnexin and/or calreticulin 
and the associated chaperones and foldases that assist their folding
96
. The mechanism by 
which UGGT recognizes and glucosylates a large variety of misfolded glycoprotein substrates 
remains unknown. 
The N-terminal ~1200 residues of UGGT harbor the enzyme’s misfold sensing 
activity 
97,98
. The lack of any obvious sequence homology of this portion of UGGT with 
proteins of known fold led to the creation of a UGGT-specific protein fold family (Pfam 
family PF06427) which gathers all known eukaryotic UGGT N-terminal sequences. The most 
recent secondary structure and domain boundary predictions for UGGT detected three 
thioredoxin-like (TRXL) domains in this region
99,100
. The canonical TRXL fold (Pfam family 
PF13848) comprises a thioredoxin fold (a four-stranded beta sheet sandwiched between three 
alpha helices, TRX=βαβ−αββα Pfam family PF00085, red in Figure 10), modified by the 
insertion of a 4-helix subdomain (TRXL=βαβ−αααα−αββα blue in Figure 10)101,102. 
To aid our understanding of UGGT structure and function, we determined four distinct 
crystal structures of Chaetomium thermophilum UGGT, aka CtUGGT. An unexpected 
structural feature of the UGGT molecule is the unusual subdomain structure of the first 
thioredoxin-like domain (TRXL1), encoded by residues 43-216 in CtUGGT. The published 
sequence–based secondary structure predictions in this region was rather accurate, with most 
helices and sheets correctly predicted from sequence – but the UGGT TRXL1 domain 
boundaries were not well predicted 
101,102
. 
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Indeed, the UGGT TRXL1 domain folds with sequential pairing of a helical 
subdomain with a thioredoxin subdomain (blue and red in Figure 10), while all other known 
TRXL domains present a helical subdomain as an insertion within the thioredoxin subdomain 
(see for example in Figure 10B the closest structural homologue of CtUGGT TRXL1, 
Staphylococcus aureus DsbA, PDB ID 3BD2). The CtUGGT crystal structures also reveal 
that the CtUGGT TRXL1 domain harbors a disulfide bridge between Cys138 and Cys150 
(represented as spheres in Figure 10A). 
We submitted the CtUGGT TRXL1 sequence to CASP12 (target T0892) in order to 
test prediction methods for their ability to model i) its non-canonical subdomain structure, in 
which an N-terminal α−helical subdomain is followed by a C-terminal thioredoxin subdomain 
and ii) the presence of a disulfide bridge between CtUGGT TRXL1 C138 and C150. 
We compare here the top 10 CASP12 T0892 models (as ranked by the GDT_TS score 
on the CASP12 results server) to the coordinates of the TRXL1 domain in the 2.8 Å CtUGGT 
crystal structure (PDB ID 5NV4), residues 43-216. The overall RMSDCα across the ensemble 
of the top ten T0892 models is 10.7 Å over 174 Cαs
103
. All these CASP12 T0892 models 
predict an N-terminal 4-helix subdomain followed by a C-terminal subdomain which 
resembles to various degrees a TRX fold. None of the top T0892 CASP12 models predicts the 
CtUGGT TRXL1 C138-C150 disulfide bond. 
If one restricts the analysis to the CtUGGT TRXL1 N-terminal helical subdomain 
(residues 43-110) and the first α-helix (residues 111-126) of the C-terminal thioredoxin 
subdomain, the top ten T0892 models align rather well with each other and with the crystal 
structure. The overall RMSDCα for the ten structures over these 84 Cαs is 1.7 Å. The major 
differences between the CASP12 T0892 models in the 43-126 portion arise at the hinge 
Page 46 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 46 
 
(CtUGGT residues 108-111, denoted by a black star in Figure 10C) between the helical 
subdomain and the first α-helix of the thioredoxin subdomain. The two top-ranked CASP12 
models (T0892TS011_1 and T0892TS011_2, green and cyan in Figures 10C-D) show a 
different hinge region from the rest. As a result of these differences, in the same top-ranking 
two models, the relative angle between the N-terminal helical subdomain and the first helix of 
the thioredoxin subdomain also differs from the crystal structure and the rest of the T0892 
CASP12 ensemble of models. The CtUGGT 111-126 α-helix is marked by a dotted circle in 
Figure 10C. 
 
 
Figure 10.  
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In the C-terminal thioredoxin subdomain (residues 111-216), the top ten CASP12 
T0892 models align poorly with each other and with the crystal structure of the target. The 
overall RMSDCα for the ten models over these 84 Cαs is 9.5 Å
103
. Only the two top ranking 
CASP12 T0892 models (T0892TS011_1 and T0892TS011_2, green and cyan in Figures 10C-
D) correctly contain a 4-stranded beta-sheet at the center of the TRXL1 thioredoxin 
subdomain. Even restricting attention to these two models only, across residues 127-216 the 
RMSDCα between the models and the crystal structure is still as high as 6.5 Å over 90 Cαs
103
 
(see Figure 10D). In particular, the first two β-strands of the thioredoxin subdomain β-sheet in 
the models do not superimpose well on the same β-strands in the crystal structure (circled in 
Figure 10D). Moreover, in both models, the stretch of sequence 151-164 – which immediately 
follows those strands - is wrongly predicted to fold as an α-helix (marked by an asterisk in 
Figure 10D) which is not present in the crystal structure. 
Overall, none of the models predict the CtUGGT TRXL1 C138-C150 disulfide bond, 
and the 128-181 region between the first TRX helix, and the third TRX strand is not well 
defined in any of the models. On the other hand, the best CASP12 T0892 models are 
successful in predicting the structure of the N-terminal 4-helix subdomain, and the two top-
scoring ones also manage to correctly predict that the domain is a linear fusion of an N-
terminal 4-helix subdomain and a C-terminal subdomain of TRX fold. In summary, as far as 
this target was concerned, the CASP12 predictors did well, but did not put us out of our job 
just yet. 
 
12. Structural characterization of the third cohesin from Ruminococcus 
flavefaciens scaffoldin protein, ScaB (RfCohScaB3) complexed with a group 1a 
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dockerin (RfDoc1a) (CASP: T0921/T0922; PDB: 5AOZ (RfCohScaB3), 5M2O 
(RfCohScaB3-Doc1a complex) – provided by Pedro Bule, Ana Luisa Carvalho, 
Carlos M.G.A. Fontes and Shabir Najmudin. 
 
The plant cell wall represents a major untapped global source of carbon and energy. It 
is especially important for herbivores, as they are able to utilize this energy source thanks to 
the presence of cellulolytic bacteria in their gastrointestinal tract. Ruminococcus flavefaciens, 
a Gram-positive Firmicutes, is a major symbiont in the rumen. It possesses multi-enzyme 
complexes termed cellulosomes, which comprise a range of cellulases and hemicellulases that 
degrade the structural polysaccharides in a highly efficient and concerted way. The assembly 
of cellulosomes occurs via highly ordered protein–protein interactions between cohesins 
(Cohs), which are located in a macromolecular scaffold (scaffoldin), and dockerins (Docs), 
which are found in the enzymes or on the scaffoldins themselves 
104,105
. Strain FD-1 of R. 
flavefaciens produces one of the most intricate and potentially versatile cellulosomes 
described to date. The R. flavefaciens FD-1 genome encodes 223 dockerin-bearing proteins, 
with the majority of them being carbohydrate-active enzymes 
106
. In this highly elaborate 
cellulosome, scaffoldin B (ScaB) acts as the backbone to which other components attach. It 
comprises 9 cohesins of 2 distinct types. Cohesins 1 to 4 are similar to the 2 cohesins on 
ScaA, while cohesins 5 to 9 are closer to the ones found in ScaB of R. flavefaciens strain 17. 
It also has a dockerin with an X-module that binds to the cohesin on ScaE attached to the 
bacterial cell wall. The ScaA dockerin binds to the second type of ScaB cohesins allowing 
more carbohydrate active modules to bind to the complex. ScaC acts as an adaptor that binds 
to both ScaA and the first type ScaB cohesins, thus serving to increase the repertoire of 
proteins that can be in the complex. In Clostridium species studied so far, enzyme-borne Docs 
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interact with their cognate Cohs through a dual-binding mode 
105
. They can bind in either of 
two orientations resulting in two different Coh-Doc conformations, related by a ~180° 
rotation.  This dual-binding mode results from the characteristic internal symmetry of the Doc 
sequence and is believed to add flexibility to the cellulosomal macromolecular organization. 
Recent studies have shown that groups 3 and 6 R.  flavefaciens Docs display a single-binding 
mode for their target Cohs 
107
. Group 1 Docs also do not seem to possess the internal 
sequence symmetry required to support the dual-binding mode. Thus, it would be interesting 
to see if modelling studies would be able to predict the correct binding mode between various 
types of Coh-Doc complexes and if they could predict which amino acid residues act as 
molecular specificity determinants. 
 
 
Figure 11. 
 
X-ray crystal structures of the third R.  flavefaciens cohesin from ScaB (RfCohScaB3) 
and group 1 Doc (RfDoc1a) in complex with RfCohScaB3 (Figure 11a) were recently solved, 
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and characterized by comprehensive biochemical analyses 
108
. RfScaBCoh3 forms an 
elongated nine-stranded β-sandwich in a classical jelly-roll topology. One face of the 
molecule is formed by anti-parallel β-strands 8, 3, 6, 5, and the other by β-strands 9, 1, 2, 7, 4, 
with the jelly roll completed by β-strands 1and 9 aligning parallel to each other. The flat 
surface formed by β-strands 8, 3, 6, 5 constitutes the Doc-interacting surface. Despite the very 
low sequence similarity, the overall RfScaBCoh3 structure is similar to other enzyme-borne 
Doc binding Cohs, with major differences in the Doc binding interface. The loops between β-
strands 6 and 7, and 8 and 9 of RfCohScaB3 are slightly raised to form a rim at one edge of 
the flat surface. RfDoc1a structure in complex with RfCohScaB3 comprises two α-helices 
(helix-1 and -3) arranged in antiparallel orientation connected by two loops either side of a 
seven-residue α-helix (helix-2). The overall tertiary structure of RfDoc1a is also very similar 
to other enzyme-borne Docs and contains two Ca
2+
 ions coordinated by several amino-acid 
residues, similar to the canonical EF-hand loop motif described in all other Docs 
105
. The 
whole of helix-1 makes predominantly hydrophobic interactions with the Coh, while helix-3 
interacts mainly through its C-terminus. Ile-39 and Val-43 on helix-1 of the RfDoc1a and Ala-
38 and Leu-79 on the binding platform of RfCohScaB3 were shown to be the key specificity 
determinants by substituting these residues in ITC experiments. Thus, the X-ray crystal 
structure of R.  flavefaciens group 1 Doc (RfDoc1a) in complex with a ScaB (RfCohScaB3) 
together with comprehensive biochemical analyses suggest that integration of a large 
repertoire of enzymes into the R.  flavefaciens cellulosome operates through a single-binding 
mode unlike in the simpler Clostridia cellulosomes 
108
. 
How do these experimental observations match with the modelling studies of 
CASP12? Predictions for both the  RfCohScaB3 and RfDoc1a were very successful, with 147 
models for the former and 143 out of 186 for the latter having GDT_TS scores greater than 
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50. The top model for each target and a slightly poorer model scoring ~10 GDT_TS below the 
top model were chosen for comparative purposes.  For RfCohScaB3, these were models 
T0921TS220 from the GOAL group (GDT_TS of 70.65) and T0921TS452 from the Zhou-
Sparks-X group (GDT_TS of 60.69). Superpositions of these models using SSM onto the X-
ray structure gave r.m.s.d. of 2.11 Å for 127 C atoms and  2.37 Å for 120 C atoms, 
respectively (Figure 11b). It can be seen that though the core structure matches really well, 
there are major differences in the 6-7 and 8-9 loops and in the 8 strand on the dockerin 
binding interface. Ala 38 is generally in the correct position, but there is considerable 
variation in the Leu 79 position. For RfDoc1a, we chose T0922TS005 from the Baker-Rosetta 
group (the top scorer with GDT_TS of 83.78) and T0922TS077 from the Falcon_Topo group 
(GDT_TS of 73.65).  Superpositions of these models using SSM onto the X-ray structure 
gave r.m.s.d. of 1.36 Å for 69 C atoms and 1.63 Å for 63 C atoms, respectively (Figure 
11c). Generally, the -helices 1 and 3 are well modelled and consequently so are the key 
specificity residues, like Leu 39 and Val 43, with differences mainly in the loop regions and 
N- and C-termini. With the modelling of the RfCohScaB3-Doc1a heterocomplex, it was a 
different story, with only three models out of 325 (TS203_4 from the Seok group, TS188_1 
from the Chuo_U group and TS208_3 from the SVMQA group) correctly modeling half or 
more of the intermolecular surface contacts compared to the crystal structure. One reason for 
this could be incorrect modelling of the loops in the binding surface of the cohesins. In these 
three predicted complexes the cohesins have similar or less prominent loops between β-
strands 6 & 7, and 8 & 9 compared to the crystal structure (cf. Figure 11b), thus avoiding 
steric clashes when complexing with the cognate dockerin models in the single-binding mode.  
 
Page 52 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 52 
 
Acknowledgements 
CASP experiment and open access fees for this manuscript are supported by the US 
National Institute of General Medical Sciences (NIGMS/NIH), grant number GM100482.  
T0859: Grant sponsor: the Latvian Council of Sciences, grant number: 12.094; Grant 
sponsor: the European Regional Development Fund, grant number: 2010/0314/2DP/2.1.1.1.0/ 
10/APIA/VIAA/052); Grant sponsor: Biostruct-X and the Latvian-French cooperation 
program Osmosis, grant number: 7869.  
T0884/T0885: Grant sponsor: National Institutes of Health, grant number: GM102318 
(CWG, CSH & subcontract to AJ); Grant sponsor: National Institutes of Health, grant 
number: GM094585 (to AJ); Grant sponsor: National Institutes of Health, grant number: 
GM115586 (to AJ); Grant sponsor: U. S. Department of Energy, Office of Biological and 
Environmental Research, contract number: DE-AC02-06CH11357 (to AJ)  
T0889: Initial funding for structure determination was from the European 
Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement No. 
NMP3-SL-2008-213487. Thanks to Harm Otten and Jens-Christian N. Poulsen for their 
contributions to structure determination of BjSDH. 
T0948: Grant sponsor: National Institutes of Health (NIH), grant number: 
R01GM102810 (to OH and JM). 
T0877: Grant sponsor: Israel Science Foundation (ISF), grant number 682/16 to RD. 
T0892: ATC and JCH were funded by Wellcome Trust 4-year Studentships 
097300/Z/11/Z and 106272/Z/14/Z, respectively; NZ is a Fellow of Merton College, Oxford. 
T0909: Grant sponsor: Spanish Ministry of Economy, Industry and Competitiveness, 
grant number BFU2014-53425-P (to MJvR). 
Page 53 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 53 
 
T0921/T0922: Grant sponsor: Fundação para a Ciência e a Tecnologia (Lisbon, 
Portugal), grant numbers PTDC/BIA-MIC/5947/2014 and RECI/BBB-BEP/0124/2012, and 
SFRH/BD/86821/2012 to PB.  
 
References 
1. Kryshtafovych A, Moult J, Bartual SG, Bazan JF, Berman H, Casteel DE, Christodoulou E, 
Everett JK, Hausmann J, Heidebrecht T, Hills T, Hui R, Hunt JF, Seetharaman J, Joachimiak A, 
Kennedy MA, Kim C, Lingel A, Michalska K, Montelione GT, Otero JM, Perrakis A, Pizarro JC, 
van Raaij MJ, Ramelot TA, Rousseau F, Tong L, Wernimont AK, Young J, Schwede T. Target 
highlights in CASP9: Experimental target structures for the critical assessment of techniques 
for protein structure prediction. Proteins 2011;79 Suppl 10:6-20. 
2. Kryshtafovych A, Moult J, Bales P, Bazan JF, Biasini M, Burgin A, Chen C, Cochran FV, Craig TK, 
Das R, Fass D, Garcia-Doval C, Herzberg O, Lorimer D, Luecke H, Ma X, Nelson DC, van Raaij 
MJ, Rohwer F, Segall A, Seguritan V, Zeth K, Schwede T. Challenging the state of the art in 
protein structure prediction: Highlights of experimental target structures for the 10th Critical 
Assessment of Techniques for Protein Structure Prediction Experiment CASP10. Proteins 
2014;82 Suppl 2:26-42. 
3. Kryshtafovych A, Moult J, Basle A, Burgin A, Craig TK, Edwards RA, Fass D, Hartmann MD, 
Korycinski M, Lewis RJ, Lorimer D, Lupas AN, Newman J, Peat TS, Piepenbrink KH, Prahlad J, 
van Raaij MJ, Rohwer F, Segall AM, Seguritan V, Sundberg EJ, Singh AK, Wilson MA, Schwede 
T. Some of the most interesting CASP11 targets through the eyes of their authors. Proteins 
2016;84 Suppl 1:34-50. 
4. Duan Q, Zhou M, Zhu L, Zhu G. Flagella and bacterial pathogenicity. J Basic Microbiol 
2013;53(1):1-8. 
5. Arora SK, Ritchings BW, Almira EC, Lory S, Ramphal R. The Pseudomonas aeruginosa flagellar 
cap protein, FliD, is responsible for mucin adhesion. Infect Immun 1998;66(3):1000-1007. 
6. Berg HC. The rotary motor of bacterial flagella. Annu Rev Biochem 2003;72:19-54. 
7. Yonekura K, Maki S, Morgan DG, DeRosier DJ, Vonderviszt F, Imada K, Namba K. The bacterial 
flagellar cap as the rotary promoter of flagellin self-assembly. Science 2000;290(5499):2148-
2152. 
8. Kim JS, Chang JH, Chung SI, Yum JS. Molecular cloning and characterization of the 
Helicobacter pylori fliD gene, an essential factor in flagellar structure and motility. J Bacteriol 
1999;181(22):6969-6976. 
9. Maki-Yonekura S, Yonekura K, Namba K. Domain movements of HAP2 in the cap-filament 
complex formation and growth process of the bacterial flagellum. Proc Natl Acad Sci U S A 
2003;100(26):15528-15533. 
10. Yonekura K, Maki-Yonekura S, Namba K. Complete atomic model of the bacterial flagellar 
filament by electron cryomicroscopy. Nature 2003;424(6949):643-650. 
11. Postel S, Deredge D, Bonsor DA, Yu X, Diederichs K, Helmsing S, Vromen A, Friedler A, Hust 
M, Egelman EH, Beckett D, Wintrode PL, Sundberg EJ. Bacterial flagellar capping proteins 
adopt diverse oligomeric states. Elife 2016;5. 
12. Galkin VE, Yu X, Bielnicki J, Heuser J, Ewing CP, Guerry P, Egelman EH. Divergence of 
quaternary structures among bacterial flagellar filaments. Science 2008;320(5874):382-385. 
Page 54 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 54 
 
13. Song WS, Cho SY, Hong HJ, Park SC, Yoon SI. Self-Oligomerizing Structure of the Flagellar Cap 
Protein FliD and Its Implication in Filament Assembly. J Mol Biol 2017;429(6):847-857. 
14. Hepatitis B vaccines: WHO position paper--recommendations. Vaccine 2010;28(3):589-590. 
15. Jennings GT, Bachmann MF. The coming of age of virus-like particle vaccines. Biol Chem 
2008;389(5):521-536. 
16. Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM. The influence 
of antigen organization on B cell responsiveness. Science 1993;262(5138):1448-1451. 
17. Pumpens P, Renhofa R, Dishlers A, Kozlovska T, Ose V, Pushko P, Tars K, Grens E, Bachmann 
MF. The True Story and Advantages of RNA Phage Capsids as Nanotools. Intervirology 
2016;59(2):74-110. 
18. Koning RI, Gomez-Blanco J, Akopjana I, Vargas J, Kazaks A, Tars K, Carazo JM, Koster AJ. 
Asymmetric cryo-EM reconstruction of phage MS2 reveals genome structure in situ. Nat 
Commun 2016;7:12524. 
19. Valegard K, Liljas L, Fridborg K, Unge T. The three-dimensional structure of the bacterial virus 
MS2. Nature 1990;345(6270):36-41. 
20. Golmohammadi R, Fridborg K, Bundule M, Valegard K, Liljas L. The crystal structure of 
bacteriophage Q beta at 3.5 A resolution. Structure 1996;4(5):543-554. 
21. Tars K, Bundule M, Fridborg K, Liljas L. The crystal structure of bacteriophage GA and a 
comparison of bacteriophages belonging to the major groups of Escherichia coli leviviruses. J 
Mol Biol 1997;271(5):759-773. 
22. Tars K, Fridborg K, Bundule M, Liljas L. The three-dimensional structure of bacteriophage PP7 
from Pseudomonas aeruginosa at 3.7-A resolution. Virology 2000;272(2):331-337. 
23. Persson M, Tars K, Liljas L. PRR1 coat protein binding to its RNA translational operator. Acta 
Crystallogr D Biol Crystallogr 2013;69(Pt 3):367-372. 
24. Plevka P, Kazaks A, Voronkova T, Kotelovica S, Dishlers A, Liljas L, Tars K. The structure of 
bacteriophage phiCb5 reveals a role of the RNA genome and metal ions in particle stability 
and assembly. J Mol Biol 2009;391(3):635-647. 
25. Tissot AC, Renhofa R, Schmitz N, Cielens I, Meijerink E, Ose V, Jennings GT, Saudan P, 
Pumpens P, Bachmann MF. Versatile virus-like particle carrier for epitope based vaccines. 
PLoS One 2010;5(3):e9809. 
26. Shishovs M, Rumnieks J, Diebolder C, Jaudzems K, Andreas LB, Stanek J, Kazaks A, Kotelovica 
S, Akopjana I, Pintacuda G, Koning RI, Tars K. Structure of AP205 Coat Protein Reveals Circular 
Permutation in ssRNA Bacteriophages. J Mol Biol 2016;428(21):4267-4279. 
27. Ruhe ZC, Low DA, Hayes CS. Bacterial contact-dependent growth inhibition. Trends Microbiol 
2013;21(5):230-237. 
28. Willett JL, Ruhe ZC, Goulding CW, Low DA, Hayes CS. Contact-Dependent Growth Inhibition 
(CDI) and CdiB/CdiA Two-Partner Secretion Proteins. J Mol Biol 2015;427(23):3754-3765. 
29. Aoki SK, Malinverni JC, Jacoby K, Thomas B, Pamma R, Trinh BN, Remers S, Webb J, Braaten 
BA, Silhavy TJ, Low DA. Contact-dependent growth inhibition requires the essential outer 
membrane protein BamA (YaeT) as the receptor and the inner membrane transport protein 
AcrB. Mol Microbiol 2008;70(2):323-340. 
30. Ruhe ZC, Nguyen JY, Xiong J, Koskiniemi S, Beck CM, Perkins BR, Low DA, Hayes CS. CdiA 
Effectors Use Modular Receptor-Binding Domains To Recognize Target Bacteria. MBio 
2017;8(2). 
31. Ruhe ZC, Wallace AB, Low DA, Hayes CS. Receptor polymorphism restricts contact-dependent 
growth inhibition to members of the same species. MBio 2013;4(4). 
32. Morse RP, Nikolakakis KC, Willett JL, Gerrick E, Low DA, Hayes CS, Goulding CW. Structural 
basis of toxicity and immunity in contact-dependent growth inhibition (CDI) systems. Proc 
Natl Acad Sci U S A 2012;109(52):21480-21485. 
Page 55 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 55 
 
33. Aoki SK, Diner EJ, de Roodenbeke CT, Burgess BR, Poole SJ, Braaten BA, Jones AM, Webb JS, 
Hayes CS, Cotter PA, Low DA. A widespread family of polymorphic contact-dependent toxin 
delivery systems in bacteria. Nature 2010;468(7322):439-442. 
34. Nikolakakis K, Amber S, Wilbur JS, Diner EJ, Aoki SK, Poole SJ, Tuanyok A, Keim PS, Peacock S, 
Hayes CS, Low DA. The toxin/immunity network of Burkholderia pseudomallei contact-
dependent growth inhibition (CDI) systems. Mol Microbiol 2012;84(3):516-529. 
35. Aoki SK, Webb JS, Braaten BA, Low DA. Contact-dependent growth inhibition causes 
reversible metabolic downregulation in Escherichia coli. J Bacteriol 2009;191(6):1777-1786. 
36. Jamet A, Jousset AB, Euphrasie D, Mukorako P, Boucharlat A, Ducousso A, Charbit A, Nassif X. 
A new family of secreted toxins in pathogenic Neisseria species. PLoS Pathog 
2015;11(1):e1004592. 
37. Zhang D, de Souza RF, Anantharaman V, Iyer LM, Aravind L. Polymorphic toxin systems: 
Comprehensive characterization of trafficking modes, processing, mechanisms of action, 
immunity and ecology using comparative genomics. Biol Direct 2012;7:18. 
38. Zhang D, Iyer LM, Aravind L. A novel immunity system for bacterial nucleic acid degrading 
toxins and its recruitment in various eukaryotic and DNA viral systems. Nucleic Acids Res 
2011;39(11):4532-4552. 
39. Carr S, Walker D, James R, Kleanthous C, Hemmings AM. Inhibition of a ribosome-inactivating 
ribonuclease: the crystal structure of the cytotoxic domain of colicin E3 in complex with its 
immunity protein. Structure 2000;8(9):949-960. 
40. Ng CL, Lang K, Meenan NA, Sharma A, Kelley AC, Kleanthous C, Ramakrishnan V. Structural 
basis for 16S ribosomal RNA cleavage by the cytotoxic domain of colicin E3. Nat Struct Mol 
Biol 2010;17(10):1241-1246. 
41. Jiang Y, Pogliano J, Helinski DR, Konieczny I. ParE toxin encoded by the broad-host-range 
plasmid RK2 is an inhibitor of Escherichia coli gyrase. Mol Microbiol 2002;44(4):971-979. 
42. Pedersen K, Zavialov AV, Pavlov MY, Elf J, Gerdes K, Ehrenberg M. The bacterial toxin RelE 
displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 2003;112(1):131-140. 
43. Masaki H, Ogawa T. The modes of action of colicins E5 and D, and related cytotoxic tRNases. 
Biochimie 2002;84(5-6):433-438. 
44. Li Z, Gao Y, Nakanishi H, Gao X, Cai L. Biosynthesis of rare hexoses using microorganisms and 
related enzymes. Beilstein J Org Chem 2013;9:2434-2445. 
45. Wang Z, Etienne M, Quiles F, Kohring GW, Walcarius A. Durable cofactor immobilization in 
sol-gel bio-composite thin films for reagentless biosensors and bioreactors using 
dehydrogenases. Biosens Bioelectron 2012;32(1):111-117. 
46. Gauer S, Wang Z, Otten H, Etienne M, Bjerrum MJ, Lo Leggio L, Walcarius A, Giffhorn F, 
Kohring GW. An L-glucitol oxidizing dehydrogenase from Bradyrhizobium japonicum USDA 
110 for production of D-sorbose with enzymatic or electrochemical cofactor regeneration. 
Appl Microbiol Biotechnol 2014;98(7):3023-3032. 
47. Kant R, Tabassum R, Gupta BD. A highly sensitive and distinctly selective D-sorbitol biosensor 
using SDH enzyme entrapped Ta2O5 nanoflowers assembly coupled with fiber optic SPR. 
Sensor Actuat B-Chem 2017;242:810-817. 
48. Fredslund F, Otten H, Gemperlein S, Poulsen JC, Carius Y, Kohring GW, Lo Leggio L. Structural 
characterization of the thermostable Bradyrhizobium japonicumD-sorbitol dehydrogenase. 
Acta Crystallogr F Struct Biol Commun 2016;72(Pt 11):846-852. 
49. Karplus PA, Diederichs K. Linking crystallographic model and data quality. Science 
2012;336(6084):1030-1033. 
50. Javidpour P, Pereira JH, Goh EB, McAndrew RP, Ma SM, Friedland GD, Keasling JD, Chhabra 
SR, Adams PD, Beller HR. Biochemical and structural studies of NADH-dependent FabG used 
to increase the bacterial production of fatty acids under anaerobic conditions. Appl Environ 
Microbiol 2014;80(2):497-505. 
Page 56 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 56 
 
51. MacKenzie AK, Kershaw NJ, Hernandez H, Robinson CV, Schofield CJ, Andersson I. Clavulanic 
acid dehydrogenase: structural and biochemical analysis of the final step in the biosynthesis 
of the beta-lactamase inhibitor clavulanic acid. Biochemistry 2007;46(6):1523-1533. 
52. Philippsen A, Schirmer T, Stein MA, Giffhorn F, Stetefeld J. Structure of zinc-independent 
sorbitol dehydrogenase from Rhodobacter sphaeroides at 2.4 A resolution. Acta Crystallogr D 
Biol Crystallogr 2005;61(Pt 4):374-379. 
53. Tamura M, Tanaka S, Fujii T, Aoki A, Komiyama H, Ezawa K, Sumiyama K, Sagai T, Shiroishi T. 
Members of a novel gene family, Gsdm, are expressed exclusively in the epithelium of the 
skin and gastrointestinal tract in a highly tissue-specific manner. Genomics 2007;89(5):618-
629. 
54. Carl-McGrath S, Schneider-Stock R, Ebert M, Rocken C. Differential expression and 
localisation of gasdermin-like (GSDML), a novel member of the cancer-associated GSDMDC 
protein family, in neoplastic and non-neoplastic gastric, hepatic, and colon tissues. Pathology 
2008;40(1):13-24. 
55. Hergueta-Redondo M, Sarrio D, Molina-Crespo A, Vicario R, Bernado-Morales C, Martinez L, 
Rojo-Sebastian A, Serra-Musach J, Mota A, Martinez-Ramirez A, Castilla MA, Gonzalez-Martin 
A, Pernas S, Cano A, Cortes J, Nuciforo PG, Peg V, Palacios J, Pujana MA, Arribas J, Moreno-
Bueno G. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast 
cancer. Oncotarget 2016;7(35):56295-56308. 
56. Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe 
A, Rietschel E, Heinzmann A, Simma B, Frischer T, Willis-Owen SA, Wong KC, Illig T, Vogelberg 
C, Weiland SK, von Mutius E, Abecasis GR, Farrall M, Gut IG, Lathrop GM, Cookson WO. 
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. 
Nature 2007;448(7152):470-473. 
57. Saleh NM, Raj SM, Smyth DJ, Wallace C, Howson JM, Bell L, Walker NM, Stevens HE, Todd JA. 
Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 
1 diabetes. Diabetes Metab Res Rev 2011;27(8):838-843. 
58. Pal LR, Moult J. Genetic Basis of Common Human Disease: Insight into the Role of Missense 
SNPs from Genome-Wide Association Studies. J Mol Biol 2015;427(13):2271-2289. 
59. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma 
Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, 
Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, 
Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, 
Buning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, 
Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, 
Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, 
Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, 
Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter 
JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, 
Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, 
Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, 
Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, 
Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe 
interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 
2012;491(7422):119-124. 
60. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, 
Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, Consortium B, 
Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, 
Criswell LA, Crusius JB, Cui J, de Bakker PI, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, 
Hocking LJ, Huizinga TW, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, 
Page 57 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 57 
 
Posthumus MD, Radstake TR, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, 
Thomson W, van der Helm-van Mil AH, van der Horst-Bruinsma IE, van der Schoot CE, van 
Riel PL, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP, Consortium Y, Wijmenga C, 
Karlson EW, Toes RE, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, 
Klareskog L, Plenge RM. Genome-wide association study meta-analysis identifies seven new 
rheumatoid arthritis risk loci. Nat Genet 2010;42(6):508-514. 
61. Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker 
RE, Kang HM, Marth GT, McVean GA. An integrated map of genetic variation from 1,092 
human genomes. Nature 2012;491(7422):56-65. 
62. Chao KL, Kulakova L, Herzberg O. Gene polymorphism linked to increased asthma and IBD 
risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein. Proc Natl 
Acad Sci U S A 2017;114(7):E1128-E1137. 
63. Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. Pore-forming activity and 
structural autoinhibition of the gasdermin family. Nature 2016;535(7610):111-116. 
64. Hergueta-Redondo M, Sarrio D, Molina-Crespo A, Megias D, Mota A, Rojo-Sebastian A, 
Garcia-Sanz P, Morales S, Abril S, Cano A, Peinado H, Moreno-Bueno G. Gasdermin-B 
promotes invasion and metastasis in breast cancer cells. PLoS One 2014;9(3):e90099. 
65. Zong M, Fofana I, Choe H. Human and host species transferrin receptor 1 use by North 
American arenaviruses. J Virol 2014;88(16):9418-9428. 
66. Fulhorst CF, Bowen MD, Ksiazek TG, Rollin PE, Nichol ST, Kosoy MY, Peters CJ. Isolation and 
characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 
1996;224(1):114-120. 
67. Blokland JA, Vossepoel AM, Bakker AR, Pauwels EK. Automatic assignment of elliptical ROIs: 
first results in planar scintigrams of the left ventricle. Eur J Nucl Med 1989;15(2):87-92. 
68. Frankel AI, Chapman JC, Cook B. The testicular response to hemicastration in the male rat 
cannot be maintained in vitro. J Endocrinol 1989;121(1):43-48. 
69. O'Neill MA, Ishii T, Albersheim P, Darvill AG. Rhamnogalacturonan II: structure and function 
of a borate cross-linked cell wall pectic polysaccharide. Annu Rev Plant Biol 2004;55:109-139. 
70. Matsunaga T, Ishii T, Matsumoto S, Higuchi M, Darvill A, Albersheim P, O'Neill MA. 
Occurrence of the primary cell wall polysaccharide rhamnogalacturonan II in pteridophytes, 
lycophytes, and bryophytes. Implications for the evolution of vascular plants. Plant Physiol 
2004;134(1):339-351. 
71. Ndeh D, Rogowski A, Cartmell A, Luis AS, Basle A, Gray J, Venditto I, Briggs J, Zhang X, 
Labourel A, Terrapon N, Buffetto F, Nepogodiev S, Xiao Y, Field RA, Zhu Y, O'Neill MA, 
Urbanowicz BR, York WS, Davies GJ, Abbott DW, Ralet MC, Martens EC, Henrissat B, Gilbert 
HJ. Complex pectin metabolism by gut bacteria reveals novel catalytic functions. Nature 
2017;544(7648):65-70. 
72. Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, McNulty NP, Abbott DW, Henrissat B, 
Gilbert HJ, Bolam DN, Gordon JI. Recognition and degradation of plant cell wall 
polysaccharides by two human gut symbionts. PLoS Biol 2011;9(12):e1001221. 
73. Lombard V, Golaconda Ramulu H, Drula E, Coutinho PM, Henrissat B. The carbohydrate-
active enzymes database (CAZy) in 2013. Nucleic Acids Res 2014;42(Database issue):D490-
495. 
74. Bekesi A, Pukancsik M, Muha V, Zagyva I, Leveles I, Hunyadi-Gulyas E, Klement E, 
Medzihradszky KF, Kele Z, Erdei A, Felfoldi F, Konya E, Vertessy BG. A novel fruitfly protein 
under developmental control degrades uracil-DNA. Biochem Biophys Res Commun 
2007;355(3):643-648. 
75. Pukancsik M, Bekesi A, Klement E, Hunyadi-Gulyas E, Medzihradszky KF, Kosinski J, Bujnicki 
JM, Alfonso C, Rivas G, Vertessy BG. Physiological truncation and domain organization of a 
novel uracil-DNA-degrading factor. Febs J 2010;277(5):1245-1259. 
Page 58 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 58 
 
76. Hartmann MD, Boichenko I, Coles M, Zanini F, Lupas AN, Hernandez Alvarez B. Thalidomide 
mimics uridine binding to an aromatic cage in cereblon. J Struct Biol 2014;188(3):225-232. 
77. Hartmann MD, Boichenko I, Coles M, Lupas AN, Hernandez Alvarez B. Structural dynamics of 
the cereblon ligand binding domain. PLoS ONE 2015;10(5):e0128342. 
78. Hakim M, Ezerina D, Alon A, Vonshak O, Fass D. Exploring ORFan domains in giant viruses: 
structure of mimivirus sulfhydryl oxidase R596. PLoS ONE 2012;7(11):e50649. 
79. Singh AK, Menendez-Conejero R, San Martin C, van Raaij MJ. Crystal structure of the fibre 
head domain of the Atadenovirus Snake Adenovirus 1. PLoS ONE 2014;9(12):e114373. 
80. Gorman JJ, Wallis TP, Whelan DA, Shaw J, Both GW. LH3, a "homologue" of the 
mastadenoviral E1B 55-kDa protein is a structural protein of atadenoviruses. Virology 
2005;342(1):159-166. 
81. Pantelic RS, Lockett LJ, Rothnagel R, Hankamer B, Both GW. Cryoelectron microscopy map of 
Atadenovirus reveals cross-genus structural differences from human adenovirus. J Virol 
2008;82(15):7346-7356. 
82. Bradley P, Cowen L, Menke M, King J, Berger B. BETAWRAP: successful prediction of parallel 
beta -helices from primary sequence reveals an association with many microbial pathogens. 
Proc Natl Acad Sci U S A 2001;98(26):14819-14824. 
83. Mayans O, Scott M, Connerton I, Gravesen T, Benen J, Visser J, Pickersgill R, Jenkins J. Two 
crystal structures of pectin lyase A from Aspergillus reveal a pH driven conformational 
change and striking divergence in the substrate-binding clefts of pectin and pectate lyases. 
Structure 1997;5(5):677-689. 
84. Garnham CP, Campbell RL, Walker VK, Davies PL. Novel dimeric beta-helical model of an ice 
nucleation protein with bridged active sites. BMC Struct Biol 2011;11:36. 
85. Holm L, Rosenstrom P. Dali server: conservation mapping in 3D. Nucleic Acids Res 
2010;38(Web Server issue):W545-549. 
86. Xiang Y, Leiman PG, Li L, Grimes S, Anderson DL, Rossmann MG. Crystallographic insights into 
the autocatalytic assembly mechanism of a bacteriophage tail spike. Mol Cell 2009;34(3):375-
386. 
87. Muller JJ, Barbirz S, Heinle K, Freiberg A, Seckler R, Heinemann U. An intersubunit active site 
between supercoiled parallel beta helices in the trimeric tailspike endorhamnosidase of 
Shigella flexneri Phage Sf6. Structure 2008;16(5):766-775. 
88. Steinbacher S, Miller S, Baxa U, Budisa N, Weintraub A, Seckler R, Huber R. Phage P22 
tailspike protein: crystal structure of the head-binding domain at 2.3 A, fully refined structure 
of the endorhamnosidase at 1.56 A resolution, and the molecular basis of O-antigen 
recognition and cleavage. J Mol Biol 1997;267(4):865-880. 
89. Leiman PG, Molineux IJ. Evolution of a new enzyme activity from the same motif fold. Mol 
Microbiol 2008;69(2):287-290. 
90. Bar Dolev M, Braslavsky I, Davies PL. Ice-Binding Proteins and Their Function. Annu Rev 
Biochem 2016;85:515-542. 
91. Raymond JA, DeVries AL. Adsorption inhibition as a mechanism of freezing resistance in polar 
fishes. Proc Natl Acad Sci U S A 1977;74(6):2589-2593. 
92. Yu SO, Brown A, Middleton AJ, Tomczak MM, Walker VK, Davies PL. Ice restructuring 
inhibition activities in antifreeze proteins with distinct differences in thermal hysteresis. 
Cryobiology 2010;61(3):327-334. 
93. Cid FP, Rilling JI, Graether SP, Bravo LA, Mora Mde L, Jorquera MA. Properties and 
biotechnological applications of ice-binding proteins in bacteria. FEMS Microbiol Lett 
2016;363(11). 
94. Mangiagalli M, Bar-Dolev M, Tedesco P, Natalello A, Kaleda A, Brocca S, de Pascale D, 
Pucciarelli S, Miceli C, Bravslavsky I, Lotti M. Cryo-protective effect of an ice-binding protein 
derived from Antarctic bacteria. Febs J 2017;284(1):163-177. 
Page 59 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 59 
 
95. Hanada Y, Nishimiya Y, Miura A, Tsuda S, Kondo H. Hyperactive antifreeze protein from an 
Antarctic sea ice bacterium Colwellia sp. has a compound ice-binding site without repetitive 
sequences. Febs J 2014;281(16):3576-3590. 
96. Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M. Calreticulin: one protein, one gene, 
many functions. Biochem J 1999;344 Pt 2:281-292. 
97. Arnold SM, Kaufman RJ. The noncatalytic portion of human UDP-glucose: glycoprotein 
glucosyltransferase I confers UDP-glucose binding and transferase function to the catalytic 
domain. J Biol Chem 2003;278(44):43320-43328. 
98. Guerin M, Parodi AJ. The UDP-glucose:glycoprotein glucosyltransferase is organized in at 
least two tightly bound domains from yeast to mammals. J Biol Chem 2003;278(23):20540-
20546. 
99. Zhu T, Satoh T, Kato K. Structural insight into substrate recognition by the endoplasmic 
reticulum folding-sensor enzyme: crystal structure of third thioredoxin-like domain of UDP-
glucose:glycoprotein glucosyltransferase. Sci Rep 2014;4:7322. 
100. Calles-Garcia D, Yang M, Soya N, Melero R, Menade M, Ito Y, Vargas J, Lukacs GL, Kollman JM, 
Kozlov G, Gehring K. Single-particle electron microscopy structure of UDP-
glucose:glycoprotein glucosyltransferase suggests a selectivity mechanism for misfolded 
proteins. J Biol Chem 2017. 
101. Ferrari DM, Soling HD. The protein disulphide-isomerase family: unravelling a string of folds. 
Biochem J 1999;339 ( Pt 1):1-10. 
102. Kozlov G, Maattanen P, Thomas DY, Gehring K. A structural overview of the PDI family of 
proteins. Febs J 2010;277(19):3924-3936. 
103. Theobald DL, Steindel PA. Optimal simultaneous superpositioning of multiple structures with 
missing data. Bioinformatics 2012;28(15):1972-1979. 
104. Bayer EA, Belaich JP, Shoham Y, Lamed R. The cellulosomes: multienzyme machines for 
degradation of plant cell wall polysaccharides. Annu Rev Microbiol 2004;58:521-554. 
105. Fontes CM, Gilbert HJ. Cellulosomes: highly efficient nanomachines designed to deconstruct 
plant cell wall complex carbohydrates. Annu Rev Biochem 2010;79:655-681. 
106. Dassa B, Borovok I, Ruimy-Israeli V, Lamed R, Flint HJ, Duncan SH, Henrissat B, Coutinho P, 
Morrison M, Mosoni P, Yeoman CJ, White BA, Bayer EA. Rumen cellulosomics: divergent 
fiber-degrading strategies revealed by comparative genome-wide analysis of six 
ruminococcal strains. PLoS ONE 2014;9(7):e99221. 
107. Bule P, Alves VD, Leitao A, Ferreira LM, Bayer EA, Smith SP, Gilbert HJ, Najmudin S, Fontes 
CM. Single Binding Mode Integration of Hemicellulose-degrading Enzymes via Adaptor 
Scaffoldins in Ruminococcus flavefaciens Cellulosome. J Biol Chem 2016;291(52):26658-
26669. 
108. Bule P, Alves VD, Israeli-Ruimy V, Carvalho AL, Ferreira LM, Smith SP, Gilbert HJ, Najmudin S, 
Bayer EA, Fontes CM. Assembly of Ruminococcus flavefaciens cellulosome revealed by 
structures of two cohesin-dockerin complexes. Sci Rep 2017;7(1):759. 
109. Notredame C, Higgins DG, Heringa J. T-Coffee: A novel method for fast and accurate multiple 
sequence alignment. J Mol Biol 2000;302(1):205-217. 
 
 
FIGURE CAPTIONS 
 
Page 60 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 60 
 
Figure 1. (A) Crystal structure of the Pseudomonas FliD78-405 monomer subunit in which 
the domain D3 (CASP domain D2, green), domain D2 (CASP domain D1, blue) and the 
helical region (red), which belongs to domain D1 (not evaluated in CASP), are indicated. (B) 
Side view (top panel) and top view (bottom panel) showing cartoon representations of the 
hexameric FliD78-405 crystal structure. Each monomer subunit is colored distinctly. (C) SAXS-
generated molecular envelope of the monomeric FliD1-474 with the CASP prediction model 
T0886TS036_1 (cyan). (D) Superposition of CASP prediction models T0886TS247_1_D1 
(orange) and T0886TS247_1_D2 (orange) with D2 (CASP domain D1, blue) and D3 (CASP 
domain D2, green) of the FliD78-405 monomer crystal structure. (E) Superposition of CASP 
prediction model T0886TS247_1 (orange) with the FliD78-405 monomer crystal structure 
(domain coloring as in Panel A). (F) Superposition of CASP prediction model 
T0886TS247_1 (orange) with the E. coli FliD43-416 crystal structure 5H5V (magenta). (G) 
Superposition of CASP prediction models T0886TS247_1 (orange), T0886TS011_1 (cyan), 
T0886TS064_1_1 (light blue), T0886TS411_1 (yellow) with the FliD78-405 monomer crystal 
structure (domain coloring as in Panel A). (H) Superposition of CASP prediction models 
T0886TS247_1-D2 (orange), T0886TS064_1_1-D2 (light blue), T0886TS011_1-D2 (cyan), 
T0886TS411_1-D2 (yellow), T0886TS456_1-D2 (dark grey), T0886TS173_1_1-D2 (red) 
with D3 of the FliD78-405 monomer crystal structure (green). 
 
Figure 2. Structural features of bacteriophage AP205 coat protein. Coat protein in AP205 
and related phages, such as MS2, builds very stable dimers, both monomers are shown in 
different shades of grey (panels A and B). Notice the close proximity of N- (blue) and C- 
(red) termini in dimers. 90 dimers further assemble into VLPs (panels C and D). In MS2, AB 
loop (green) is the most exposed structure on the surface of VLPs. Compared to MS2, in 
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AP205 the first beta strand (yellow) is shifted to the C-terminus, although it remains in the 
same position in 3D. As a result, in AP205, C-and N- termini are the most exposed features 
on VLPs. In panel E, crystal structure of AP205 monomer (green) is superimposed with the 
modelled structure (blue and red). The overall fold of model is approximately correct, except 
that it lacks C-terminal beta strand. Residues 1-39 (blue) are correctly placed in respect to the 
sequence, corresponding to the first four beta strands. For the rest of model (red) residues are 
placed incorrectly according to the sequence and out-of-register errors occur. Notice also that 
position of N-terminus is relatively well predicted, while C-terminus is in a very different 
position. 
 
Figure 3. The CdiA-CT/CdiI
Ctai
 complex. (A) Experimental structure with the most 
conserved residues and their interactions shown in stick representation. The CdiA-CT
Ctai
 toxin 
domain is shown in teal and the CdiI
Ctai
 immunity protein in pink. Hydrogen bonds are 
depicted as red broken lines. Superposition of CdiA-CT
Ctai
 with (B) the closest PDB homolog, 
inorganic triphosphatase (coral, PDB:3TYP), (C) with ParE toxin from E. coli (yellow, 
PDB:3KXE) and (D) with T0884TS183_1-D1 (purple) and refined TR884TS118_1 model 
(blue). β1 from CdiICtai is shown for reference. (E) Superposition of CdiICtai with 
T0885TS005_2-D1 (cyan) and refined TR885TS247_1-D1 model (blue).  
 
Figure 4. (a) Products of reaction catalyzed by BjSDH with D-glucitol and L-glucitol as 
substrates; (b) Structure based sequence alignment of region around loop 193-203 covering 
the active site of BjSDH. Sequences of GatDH, RsSDH and top 5 DALI hits searching with 
the BjSDH structure are shown; c) BjSDH structure shown as cartoon (gold) and symmetry 
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related molecule packing against is (grey). Ligands in the structure are shown as sticks, while 
loop 193-203 in top 5 models from CASP12 are shown as lines; d) Continuous β-sheet 
between two monomers in BjSDH crystal structure, and same region in the RsSDH crystal 
structure. 
 
Figure 5. (A) Structure-based sequence alignment of the GSDMB (T0948 comprises 
GSDMB’s C-terminal domain) and mouse Gsdma3 C-terminal domains with secondary 
structure elements shown above or below the respective sequences. Identical and 
conservatively replaced residues are colored in red and blue. The alignment was performed 
using the programs Clustal Omega 
109
 and ESPript 3 (espript.ibcp.fr/Espript/). (B) Ribbon 
diagram of the GSDMB_C fold (PDB 5TIB). The α7–α8 GSDMB loop containing the 
polymorphism residues is colored in red. (C) Superposition of the experimental GSDMB_C 
structure (colored yellow) and the corresponding Gsdma3 domain that served as a modeling 
template (blue, 5B5R), (D) Superposition of the experimental GSDMB_C structure (colored 
yellow) and the best GTD_TS CASP12 scored model of group 251 (green). (E) Superposition 
of the polymorphism loop of the experimental structure (colored gray with α’ highlighted in 
orange) with the corresponding loop assessed as the closest (Group 330) based on the position 
specific criterion (colored cyan with α’ highlighted in magenta).  
 
Figure 6. The structure of WWAV-GP1 compared to the top three models. (A): Ribbon 
diagrams of the WWAV-GP1 colored in rainbow and shown in a putative complex with 
hTfR1 (surface representation) (PDB ID: 3KAS). (B): A potential charge-repulsion between 
two negatively charged groups on WWAV and hTfR1 that was identified using this analysis. 
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(C): Comparison of the top three models from ‘MULTICOM-CONSTRUCT’, ‘MULTICOM-
NOVEL’, and ‘GOAL’ (designated S236, S345, and S220, respectively) with WWAV-GP1. 
(D): A close-up view comparing the loops of WWAV-GP1 that interact with hTfR1 to the top 
model. Structures were rendered using PyMOL (www.pymol.org). 
 
Figure 7. Panel A: Cartoon representation of BT1002 (5MPQ, chain A) aligned with 
T0912TS349_1 using align in pymol (sequence alignment followed by structural 
superposition with c-alpha atoms only). Residues are colored by a RMSD gradient (dark blue 
is a good alignment and red are higher deviations). Residues not used are colored grey. The 
domain are labelled D1 to D3. Panel B: Binding pocket surface representation. The predicted 
model (T0912TS303_1) surface is represented in solid dark grey and the PDB model surface 
in yellow mesh. The putative catalytic residues in the predicted model are colored magenta 
and red in the PDB model.  
 
Figure 8. The crystal structure of AaUDE(87-277) in comparison to the best DALI 
matches and CASP predictions. (A) The full crystal structure in cartoon representation. (B) 
The crystal structure (red) superimposed with the best DALI matches for the N-terminal 
(PDB: 3UN9; DALI Z-score 7.5) and the C-terminal domain (PDB: 3TD7; DALI Z-score 
10.1). (C) The two best CASP predictions for the N-terminal domain (D1), models 
T0890TS236_1 (MULTICOM-CONSTRUCT) and T0890TS486_1 (TASSER), yielded a 
GDT_TS of 68.0 and 67.7 for D1 and of 30.0 and 31.8 for the whole structure. (D) The best 
CASP predictions for the C-terminal domain (D2). T0890TS250_1 (Seok-server) yielded a 
GDT_TS of 74.8 for D2 and 44.7 for the whole structure. T0890TS119_1 represents the three 
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almost identical models T0890TS119_1 (HHPred0), T0890TS349_1 (HHPred1) and 
T0890TS313_1 (HHGG), which yielded a GDT_TS of 69.8, 69.8 and 70.5 for D2 and of 
40.8, 40.8 and 41.0 for the whole structure. T0890TS464_1 (tsspred2) yielded a GDT_TS of 
59.2 for D2 and 33.4 for the whole structure. 
 
Figure 9. Crystal structure of SnAdV-1 LH3 in comparison with CASP12 models. (A) 
Superimposition between a monomer of the experimentally determined structure (cyan) and 
best predicted model (magenta). The missing loop at the rung 7 is indicated with the black 
arrow. (B)  Predicted monomer was superposed in a trimeric structure obtained by X-ray 
crystallography. Models were colored as in the A and black arrow indicates the missing loop 
in the model. (C) and (D). 
 
Figure 10. The TRXL1 domain of CtUGGT. A. In blue, the CtUGGT TRXL1 N-terminal α-
helical subdomain (residues 43-110). In red, the TRXL1 thioredoxin subdomain (residues 
111-216). The disulphide bridge C138-C150 is represented as spheres. B. The structure of the 
closest structural homologue to CtUGGT TRXL1, Staphylococcus aureus DsbA, with the α-
helical insertion subdomain (residues 63-129) in blue and the thioredoxin subdomain 
(residues 14-62 and 130-177) in red. In (A) and (B) N- and C-termini are denoted by the 
letters “N” and “C”, respectively. (C). The superposition of the top ten CASP12 T0892 
models, overlayed on the CtUGGT TRXL1 crystal structure in the region of the N-terminal 
helical subdomain and the first helix of the thioredoxin subdomain. The CtUGGT TRXL1 
crystal structure is colored and represented as in panel A. The top ten CASP12 T0892 models 
are in ribbon representation and colored as follows: T0892TS011_1:green; T0892TS011_2: 
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cyan; T0892TS017_1: magenta; T0892TS017_2: yellow; T0892TS017_5: grey; 
T0892TS411_2; T0892TS017_3: salmon pink; T0892TS079_5: violet; T0892TS479_3: steel 
blue; T0892TS320_4: orange. A black star marks the hinge between the helical subdomain 
and the thioredoxin subdomain. A dotted circle marks the first helix in the thioredoxin 
subdomain. (D). The superposition of the top two CASP12 T0892 models (T0892TS011_1 
and T0892TS011_2, in green and cyan respectively, in ribbon representation), overlayed on 
the CtUGGT TRXL1 crystal structure in the region of the C-terminal thioredoxin subdomain, 
without its first α-helix. The CtUGGT TRXL1 crystal structure is colored and represented as 
in panel A. The wrongly predicted first two strands of the thioredoxin subdomain are circled, 
and an asterisk marks the incorrectly predicted α-helix for the stretch of residues 151-164 of 
CtUGGT TRXL1. 
 
Figure 11. Structure of the RfCohScaB3-Doc1a complex. (A) Structure of RfCohScaB3-
Doc1a complex with the dockerin in red and the cohesin in blue. The dockerin N- and C- 
terminus and the α-helices are labeled, and a transparent gray molecular surface of the cohesin 
is shown. (B) Superposition of CASP12 prediction models T0921TS220_2_D1 (light blue) 
and T0921TS166_1_D1 (light green) with RfCohScaB3 crystal structure (black). (C) 
Superposition of CASP12 prediction models T0922TS005_3_D1 (light blue) and 
T0922TS077_4_D1 (light green) with the RfDoc1a crystal structure (black). Ca
2+
 ions are 
depicted as pink spheres.  
 
Page 66 of 65
John Wiley & Sons, Inc.
PROTEINS: Structure, Function, and Bioinformatics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
